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ABSTRACT
Wood products are treated with biocides to prevent biodegradation by bacteria, fungi, and
insects. Much attention is being directed towards testing of metal-free organic preservative
systems. The major disadvantage of organics is that they are biotransformed by micro-organisms
in soil and wood.
This study explored the biotransformation of the fungicide tebuconazole by a bacteria
species (Pseudomonas fluorescens), the mold (Trichoderma harzianum), the white rot fungus
(Phanerochaete chrysosporium) and the brown rot (Meruliporia incrassata). After incubation of
cultures spiked with tebuconazole, samples were analyzed for chemical remaining and
metabolites. M. incrassata, T. harzianum, and the bacterium all cleaved the 1, 2, 4 triazole ring
on tebuconazole and performed oxidation reactions forming the alcohol and carboxylic acid
oxidation products of the tert butyl moiety on tebuconazole. P. chrysosporium which exhibited
the lowest minimum inhibitory concentration (highest tebuconazole efficacy), did not degrade
tebuconazole to measurable amounts. T. harzianum, with the highest MIC (lowest efficacy),
degraded tebuconazole to the largest extent and tolerated it at concentrations below 200ppm.
These suggested that the ability of a fungus to degrade a biocide contributes to the efficacy.
The oxidation of tebuconazole was reduced when P450 inhibitors were added to the
cultures leading to the conclusion that enzymes involved in the oxidation are cytochrome P450
dependent. Furthermore, the microsomal extract from T. harzianum exhibited a maximum peak
at 440-460nm when CO was bubbled into Na2S2O4 treated samples. Testing metal chelators
EDTA and TEMED as synergistic additives to tebuconazole showed that EDTA reduced the
magnitude of oxidation most likely by binding ions important in the enzymatic system. TEMED
had no significant effect while the P450 inhibitors PB and ABT gave the best performance in
terms of reducing tebuconazole depletion. T. harzianum was able to germinate and grow in the
presence of tebuconazole and all additives used leading to the conclusion that in addition to
ix

biotransformation, there are other mechanisms which this species uses to tolerate tebuconazole.
While molds and bacteria species are not responsible for decay, they may metabolize a biocide
into a less potent derivative making the environment more suitable to wood degrading
basidiomycetes and insects.

x

CHAPTER 1. INTRODUCTION
Solid and composite wood products are treated with biocides to prevent biodegradation by wood
attacking organisms: bacteria, fungi, and insects. Decay fungi have been responsible for annual
losses of over $1 billion in the United States to in-service wood. The combined damage from
Eastern and formosan subterranean termites exceeds $2 billion annually while mold claims,
including pre- and post-construction, exceeded $2.8 billion in 2002 (Clausen and Yang, 2004).
Heavy metals such as arsenic and chromium have undergone close environmental scrutiny
spurring efforts to replace or reduce their use in preservative water borne systems. Quats
containing more copper than traditional wood preservatives do not have the broad spectrum
activity needed for ground contact exposure (Barnes, 1993). Critical examination of chemical
systems used by the wood preservation industry and the now permanent trend towards the use of
environmentally sound materials has increased the interest in wood preservation based on boron
and purely organic systems. Much attention is currently being directed towards the formulation
and testing of metal-free preservative systems. The major components of such preservatives are
biocides originally developed for use in the agricultural sector. Organic biocides will play an
increasing role in all use classes in the future. At some point, totally organic or low metallics
will be mandated in the United States (Schultz and Nicholas, 2006).
1.1

Organic Preservatives- the Problem

Several problems exist with developing a totally organic wood preservative system. Most are
about 10-30 fold more expensive per pound than the inorganics (Schultz et al., 2004). The newer
organic agrochemicals are extremely effective at much lower doses than copper (II), but a critical
minimal retention is necessary since leaching occurs for both metallics and organics. Currently,
their major advantage is also their major disadvantage: they are biodegradable or transformed by
wood degrading and non-degrading organisms in soil and wood. Other missing elements in the
organic systems are photo protection and hydrophobicity (Evans, 2003). Chemical, and/or photo
1

degradation reactions, or volatilization reduce the biocide’s concentration in wood over time.
Consequently, at the present time in North America, no organic preservative can economically
compete with the current residential 2nd generation copper-rich systems, nor is any organic system
currently standardized for residential outdoor applications by the American Wood Protection
Association (AWPA) (Schultz et al., 2004).
The preservative tolerance of many economically important wood-destroying agents has
been studied. Tolerance is defined as the relative capacity of an organism to grow or thrive when
subjected to an unfavorable environment (Green III and Clausen, 2001). However, not much is
known of the factors involved in a specific tolerance. Several studies indicate inactivation of
compounds used in preservation of wood. These chemicals include copper, organotin
compounds, alkylammmonium compounds, and purely organic systems (Lyr, 1963; Duncan and
Deverall, 1964; Belford and Dickinson, 1985; Briscoe et al., 1990; Dubois and Ruddick, 1998;
Green III and Clausen, 2001; Schultz et al., 2004; Wallace and Dickinson, 2006). The question
of how commonly the tolerance of a preservative by a fungus may be attributed to degradation of
the preservative, through the metabolism of the wood-attacking organism or its associate, is of
particular significance to the effect of a preservative in wood upon such a synergistic fungus
association.
In an attempt to address the problems of organics, low cost and benign non-biocidal
additives may be added to enhance the efficacy and/or reduce the biodegradation of organic
biocides. Additives include antioxidants, metal chelators and water repellants (Schultz et al.,
2001; Schultz and Nicholas, 2004). A combination of various organic biocides with low-cost
non-biocidal antioxidants gives enhanced (synergistic) efficacy against wood-decaying fungi
(Binbuga et al., 2005). It has been proposed that metal chelators reduce the degradation of
organic biocides caused by molds, stains, bacteria, and decay fungi. An example of such an
additive is propyl gallate, which is both an antioxidant and a metal chelator. Combination
2

systems relying on synergism will be common place in the next century (Barnes, 1993). The
successful organic preservative is likely to be a mixture of two to three biocides to counteract
specific tolerances within the broad range of organisms threatening wood, to enhance synergies,
and to reduce costs when some individual components are expensive (Cookson and Yang, 2004;
Schultz and Nicholas, 2006).
Microbial associations, in addition to being numerous and varied, are frequently so
complex and sensitive to slight changes in environment that it is difficult to discover the primary
phenomena that contribute to the end result (Duncan and Deverall, 1964). Micro-organisms can
modify the environment often making an otherwise unsuitable environment suitable to another
micro-organism. Species diversity can be very high as in soil, or very low as in toxic
environments, such as treated wood. The highly diverse microorganisms, including non tolerant
species may be capable of detoxification at a faster rate than observed in laboratory studies
(Briscoe et al., 1990). Activity against the causal decay organisms and resistance to physical
losses are no longer the sole performance criteria that need to be understood when developing a
new wood preservative. Microbial mediated detoxification of biocides by both bacteria and
fungi may contribute significantly to the failure of treated wood (Briscoe et al., 1990). If wholly
organic wood preservatives are to be utilized in the long term in high hazard situations, such as
soil contact, it will be necessary to fully understand the biotransformation of the constituent
biocides, and attempt to control it (Wallace and Dickinson, 2006). There is a need to establish
the biotransformation pathways and use this knowledge to stabilize biocides in wood. An
understanding of the mechanisms involved in detoxification of fungicides or termiticides by
bacteria, fungi, and termites is needed to provide a means for defeating these processes.
1.2

The Study
This study utilized bacteria and fungal species which in previous studies by other

researchers have been isolated, identified and, associated with failed preservative-treated wood.
3

A bacteria species, a brown rot, a white rot, and a mold fungus were each separately used to
access in vitro the biodegradation rate and products of metabolism of tebuconazole.
Tebucanazole - is the generic name of the compound 1-(4-chlorphenyl)-4,4-dimethyl-3-(1H1,2,4-triazole-1-methyl)amyl-3-alcohol. It is a broad spectrum fungicide and a component of
copper azole a commercial preservative. This dissertation is composed of six interrelated
chapters addressing the biotransformation of tebuconazole by different classes of microorganisms.
Chapter 1 (this chapter) is an overall introduction to the dissertation. In Chapter 2, the
resistance of wood inhabiting ascomycetes to triazole based wood preservatives is studied and
discussed. Trichoderma harzianum is known to be tolerant to antisapstain compounds like
methylene-bis –thiocyanate (MBT) and was used to study biotransformation mechanisms
involved using tebuconazole as the test chemical. The alteration of the compounds by a sapstain
or mold may detoxify it to a level where wood –rotting basiodiomycetes could grow and
breakdown wood.
Chapter 3 presents the study of different classes of wood inhabiting fungi and their
capacity to biotransform tebuconazole. Species used to study different classes of fungi were: (i)
Phanerochaete chrysosporium, a white-rot fungus recognized for its ability to metabolize a large
diversity of compounds (Mendoza-Cantu et al., 2000), (ii) Meruliporia incrassata, a brown rot
fungus reported to tolerate chromated copper arsenate (CCA) and cause substantial weight loss
in pine blocks treated with CCA or copper sulphate (Illman and Highley, 1996), (iii) T.
harzianum a mold and (iv) a bacteria strain (Pseudomonas fluorescens). The results show that
the initial mechanism(s) involved in detoxifying tebuconazole by the bacteria, T. harzianum and
M. incrassata were the same. The initial metabolites were the same.
Chapter 4 describes the study of the proteineous extracellular extracts responsible for
biotransformation of tebuconazole by bacteria and wood inhabiting fungi. Each organism
4

produces proteineous extracts when subjected to media containing tebuconazole. The results
showed that although different enzymes may be produced, the cytochrome P450 family of
enzymes is involved in the initial oxidation of tebuconazole by T. harzianum and M. incrassata.
Phase I reactions result in (more) polar metabolites of tebuconazole. Phase II reactions
(conjugation reactions) were observed in cultures of T. harzianum only.
Chapter 5 addresses the issue of additives that may to slow down the degradation of
tebuconazole by micro-organisms. Additives studied were two metal chelating agents and two
enzyme inhibitors. Results in cultures containing only tebuconazole and a combination of
tebuconazole and additive were compared and presented. The chapter also presents the results of
the use of a standard mold test in the efficacy and synergies observed when tebuconazole is used
in combination with the additives. Chapter 6 provides overall conclusions for the dissertation.
Conclusions on mechanisms involved in biotransformation by the four different microorganisms
are discussed. Conclusions on methods of intervention using additives to slow down the process
of transformation are also presented.
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CHAPTER 2. RESISTANCE OF SAPSTAIN Trichoderma harzianum TO TRIAZOLESPOSSIBLE MECHANISMS INVOLVED
2.1

Introduction

Triazoles are a broad class of organic fungicides with low mammalian toxicity. Increasingly
being used in agriculture, triazoles inhibit the synthesis of sterols required for cell growth in
fungi. They inhibit the fungal cytochrome P-450 3-A dependent enzyme 14-alpha demethylase,
thereby interrupting the synthesis of ergosterol. Inhibition of this critical enzyme in the
ergosterol synthesis pathway leads to the depletion of ergosterol in the cell membrane and
accumulation of toxic intermediate sterols, causing increased membrane permeability and
inhibition of fungal growth (Lamb et al., 1999). Whereas mammalian cell membranes contain
primarily cholesterol, ergosterol is the predominant sterol in many pathogenic fungi. The
triazole tebuconazole is a broad spectrum second generation fungicide. It is a component of
copper azole a commercial wood preservative.
Tebuconazole and propaconazole act synergistically and are standardized by the
American wood preservers association (AWPA). Tebuconazole is stable, resistant to hydrolysis
at pH 4-9, can be formulated in solvent as well as water borne formulations, and is compatible
with insecticides (Grundlingerv and Exner, 1990). Efficacy data indicates efficacy of
tebuconazole against basiodiomycetes. A retention of <0.54 kg/m3 is required for white rot
Coriolus versicolar and 0.026-0.03 kg/m3 for brown rot Gloeophyllum trabeum. The dry rot
Serpula lacrymans requires a higher retention of 0.8-1.28 kg/m3 (Buschhaus, 1995). While
efficacy data for tebuconazole suggests activity against a wide range of wood degrading fungi,
triazoles appear to be less effective against ascomycetes (staining fungi and molds).
Trichoderma spp. possesses innate resistance to most chemicals, including fungicides, although
individual strains differ in their resistance. The tolerant fungus Trichoderma harzianum causes
more than 75% reduction in the concentration of preventol A4S (N,N-dimethyl-N'-phenyl-N'7

fluorodichloromethylthio sulphamide and preventol A5 (tolylfluanid) in test solutions (Briscoe
et al., 1990). It is known to be tolerant to the antisapstain compound methylene-bis –thiocyanate
(MBT) at concentrations ranging from 4ppm to 34ppm. Considerable increases in both threshold
and toxic limits have been observed when wood treated with alkylammonium compounds is first
subjected to T. harzianum and then basidiomycetes in a second step. Trichoderma spp. are
present in nearly all soils and other diverse habitats. In soil, they frequently are the most
prevalent culturable fungi. Because of tolerance of ascomycetes to triazole chemicals,
manufacturers of triazole containing formulations do not recommend them for treatment against
ascomycetes. Not much is known about the actual mechanisms used by these microorganisms
with regards to tolerance. Table 1 shows minimum inhibitory concentrations of tebuconazole to
various ascomycetes.
Table 2.1. Tebuconazole minimum inhibitory concentrations (MICs) in nutrient agar for
ascomycetes
Species
Altenaria alternata
Aspergillus niger ATCC 10575
Aureobasidium pullulans ATCC 9348
Chaetomium globusum ATCC 6205
Gliocladium virens ATCC 9645
Penicillium glaucum
Phialophora fastigiata Wfpl 234 a
Scherophoma pityophila
Trichoderma viride
Source (Grundlingerv and Exner, 1990).

MIC (ppm)
200
10
35
15
75
15
50
5
>1000

Biocide detoxification may be brought about if the biocide is rendered unavailable by adsorption
on the surface of the microbial cells. Such adsorption processes are most likely in the cases of
quaternary ammonium compounds and metal ions which dissociate to form ions in solution.
Microorganisms may detoxify a biocide by assimilation into the cell where the active ingredients
of the biocide become immobilized (e.g., in the uptake of copper from external media by a
fungus followed by the formation of insoluble copper oxalate within and around he fungal
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hyphae). The biocide may be inactivated extracellularly by becoming bound to microbial
metabolites or it is possible that metabolites produced by microorganisms may induce the
breakdown of the biocide to less toxic products (Briscoe et al., 1990). Microbial mediated
detoxification of biocides by both bacteria and fungi may contribute significantly to the failure of
treated wood. Bacteria and actinomycetes are probably the most common wood-inhabiting
microorganisms and certainly are the most adaptable in terms of environmental influences. They
can modify the environment often making an otherwise unsuitable environment suitable to
another microorganism such as decay fungi (Wallace and Dickinson, 2004). Wood-inhabiting
fungi, not necessarily responsible for major decay, have been shown to be capable of degrading a
toxic compound or metabolizing it into a less potent form or derivative, thus rendering it less
effective in protecting wood from less tolerant basidiomycetous wood-destroyers and insects
(Duncan and Deverall, 1964; Ruddick, 1984). This study uses tebuconazole as a model triazole
for the investigation of biotransformation pathways and identification of metabolites produced
by T. harzianum. The results will broaden knowledge on mechanisms used by the ascomycetes
in tolerating triazoles. Understanding the mechanisms involved in detoxification of biocides is
important to provide a means for stabilizing them in wood.
2.2

Materials and Methods

2.2.1

Test Chemicals and Fungi

Ninety five percent tebuconazole (preventol A 8) was provided by Lanxess Corporation
(Pittsburgh, PA). The tebuconazole standard was obtained from Sigma Aldrich (St. Louis, MO).
Original strains of T. harzianum were provided by the US Forest Products Laboratory,
Department of Agriculture Madison (WI). Cultures were grown out and maintained on media
containing 1.5% agar, 2% malt extract, and 0.001% yeast extract.
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2.2.2

Determination of MICs

Preliminary work involved determination of the minimal inhibition concentrations for
tebuconazole against T. harzianum. Using the same media above, plates of nutrient agar
containing tebuconazole in concentrations ranging from 0-200ppm were prepared in triplicate.
Plates were kept at room 25oC for 7 days. The MIC (the lowest concentration at which no
visible growth of mycelium was observed) was determined. Subsequent biodeterioration studies
were performed at levels lower than the MIC.
2.2.3

B3 Media Suitability

The study utilized nutrient limited B3 media. Because B3 media was studied and developed
specificaly for Phanerochaete chrysosporium’s extracellular peroxidase production, preliminary
studies were necessary to ascertain its suitability for growing T. harzianum in subsequent
degradation studies. B3 media for N-limitation represents the situation on wood which has low
amounts of nitrogen. In this preliminary study, one circular plug was obtained from one week
old cultures on petri dishes and used to inoculate 100ml of sterilized "B3"in Erlenmeyer flasks.
Twenty eight flasks were inoculated, covered with parafilm, and kept at 25oC for two weeks on a
shaker at 100rpm. Growth was monitored by weighing the dry fungal cell mass harvested by
filtering the liquids through Whatman #2 filter paper at time intervals of 0-14 days. Two flasks
were harvested every two days. The cell mass retained on filter paper was rinsed twice with
deionized water and air dried at 30°C to constant weight. The composition of B3 media per liter
of distilled water was as follows: 1.73 t-aconitic acid adjusted to pH to 4.5 with KOH, 2g
KH2PO4, 0.5g MgSO4.7H2O, 0.1g CaCl2.2H2O, 0.2g ammonium tartrate, 10g glucose, 0.001g
thiamine, and 10mls mineral elixir. The mineral elixir contained the following per liter: 1.5 g
nitrilotriacetic acid (pH adjusted to 6.5 with KOH, 3.0g MgSO4.7H20, 0.5g MnSO4.H2O, 1.0g
NaCl, 0.1g FeSO4.7H2O, 0.1g CoSO4, 0.1g CaCl2, 0.1g ZnSO4.7H2O, 0.01g CuSO4, 0.01g
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AlK(SO4)2.12H2O, 0.01g H3BO3, and 0.01g NaMoO4.2H2O. Separate flasks were grown using
the same procedure but using malt extract broth as the growth media. Malt extract broth
contained 17g/l of mycological peptone and 3 g/l of malt extract. Growth rates for the two types
of media were compared at the end of 14 days.
2.2.4

Biotransformation Studies

Erlenmeyer flasks containing 100ml of B3 media were supplemented with 0.1ml of 0.2%
tebuconazole to give a final concentration of 20 ppm of each flask. Flasks were inoculated with
an agar plug from actively growing colonies. Cultures were incubated at 25oC and shaken at
120rpm for a period ranging from 3-21days. The filtrate was separated by centrifugation (10
min. at 15000xg and 4oC). The centrifuge used was a fixed angle rotor, induction drive
Beckman model J2-21M. Three replicates were used for each time interval. A sample of 5mls
was removed from each flask for further analysis. Two controls were run simultaneously. The
culture control consisted of a media blank in which T. harzianum was grown under identical
conditions but without tebuconazole. The substrate control consisted of tebuconazole and sterile
media incubated without fungal innoculum to determine whether tebuconazole could chemically
decompose or transform under experimental conditions.
2.2.5

Quantitative Determination of Tebuconazole Retained in Samples

Five ml of filtered medium was extracted in solid-phase extraction (SPE) columns. The columns
(Bond Elut –C18, 500mg, 3ml Varian #12102028) were washed and preconditioned with two
column volumes of methanol, followed by two column volumes of milli-Q water under vacuum.
Five ml of sample was loaded and pulled through at one drop per second, followed by a column
rinse of 50:50 acetonitrile water. Retained compounds were eluted with 4 column volumes of
methanol and collected in 15ml centrifuge tubes. Each tube was dried to below 5ml on a
nitrogen evaporator and transferred to a second tube through sodium sulfate. The final volume
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was adjusted to 5ml using methanol. Samples were cleaned with a 0.2 µm Teflon™ filter prior
to quantitative analysis by gas chromatography –mass spectrometry (GC-MS). The GC-MS was
an Agilent 6890gas chromatograph using 5973 mass selective detector. The injection port
temperature was 250oC, the detector temperature 280oC, and the carrier gas was helium at 1 mm
min-1. The oven was initially held at 80oC for 2 min followed by a 30oC min-1 increase to 190oC
and then an 8oC min-1 increase to a final temperature of 300oC. The capillary column model No.
RTX35 was 30m X 250µmX 0.25µm. Injection volume was 2.0µl and total runtime was 20.42
min. Tebuconazole eluted at 15.9 min. Running in selected ion mode (SIM), ions detected for
tebuconazole were 250 as the target ion, and 125 and 252 as the qualifier ions. Calibration was
done using a four point curve. Concentrations of the samples were calculated using the formula:
(X / V1)* (V2)*dilution factor.
Where:

[1]

X = value from the curve reading from the instrument.
V1= Initial vol. of sample extracted by SPE
V2= final vol. of sample after SPE

2.2.6

Analysis of Tebuconazole Absorbed on Mycelia

To evaluate tebuconazole content adsorbed on the fungal mycelia, the biomass was filtered from
culture media after 21 days, washed with distilled water, and frozen at -32ºC before freezedrying. The dried mass was ground to small particle size, 100ml of methanol was added to it in a
flask, and shaken at 100 rpm in an orbital shaker for 24 hrs. The filtrate was separated by
centrifugation (10 min. at 15000xg and 4oC). Two repeat extractions with methanol were done
on triplicate samples ensure all the tebuconazole was extracted. The extract was subjected to
solid phase extraction prior to quantitative analysis by GC-MS.
2.2.7

Preparation of Samples for HPLC

To isolate the major metabolites in sufficient quantities for structural elucidation, the
transformation of tebuconazole by T. harzianum was carried out on a preparative scale. Ten
12

250mls Erlenmeyer flasks containing 100ml of B3 media were supplemented with 0.1ml of 0.2%
tebuconazole to give a final concentration of 20 ppm. Flasks were inoculated with an agar plug
from actively growing colonies, incubated at 25oC, shaken at 100rpm for a period of 21 days
after which they were centrifuged (10 min. at 15000xg and 4oC) to separate the mycelia and
media. The liquid samples were pooled into two equal composite samples which were then
subjected to extraction and cleanup by the following procedure: 500ml of sample was
transferred into a one liter separating funnel to which 75ml of dichloromethane was added. The
sample was subjected to shaking for 1.5 min. vented every 20 seconds to release pressure, then
left to stand for 3 min. The bottom layer was passed over sodium sulfate in a large funnel into a
400ml beaker. This extraction procedure was repeated twice. The sample was then placed on a
water bath at 45oC and evaporated until almost dry. Five 5ml. of acetonitrile was added for
solvent exchange, re-dried to about 2ml, and transferred to a centrifuge tube with several rinses
of acetonitrile while passing it over sodium sulfate funnel. The tube was dried to below 5ml on a
nitrogen evaporator, the final volume adjusted to 5ml using acetonitrile and subjected to HPLC
qualitative analysis. The culture control consisted of a blank in which T. harzianum was grown
under identical conditions but without tebuconazole. The substrate control consisted of
tebuconazole and sterile media incubated without fungi.
2.2.8

HPLC Analysis

Several reverse-phase HPLC runs were done to detect and purify any metabolites and
byproducts. The HPLC system consisted of a Waters 600 pump with a Waters 2487 UV
detector. The output from the UV detector was connected to a fraction collector. The column
was a Waters Delta-Pak C18, 300 Angstrom, 15 micron, 8mm x 10 cm radial compression
module. Eluant composition as a function of time was as follows: isocratic from 0-5 min. 70%
water + 0.1% formic acid and 30% acetonitrile, linear increases of acetonitrile from 5-30 min to
85% and isocratic at 85% acetonitrile for 5 min. Flow rate was 1 ml min-1 and detection was at
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224 nm wavelength. Tebuconazole eluted at 28 min. Fractions were evaporated in vacuum and
metabolites extracted from the remaining solution using acetonitrile.
Qualitative analysis using authentic standards of metabolites was not possible as metabolites of
tebuconazole could not be obtained. Tebuconazole peaks and those of metabolites were
identified by comparison of elution time, protonated molecular mass and identification of
functional groups of in the tebuconazole standard, media only, media containing tebuconazole
before exposure to the fungi and, media containing tebuconazole after exposure to the fungi.
2.2.9

Mass Spectral Characterizations

Exact mass determination of HPLC fractions of tebuconazole and its metabolites was performed
by electrospray ionization (ESI). The instrument operated in positive ESI mode was an Agilent
6210 Time of flight (TOF) LC/MS mass spectrometer.
2.2.10

IR Analysis

HPLC fractions and authentic tebuconazole were subjected to IR analysis to determine functional
groups retained or changed on the metabolites. The FT-IR system was a Bruker Tensor 27
system single beam instrument connected to an optical user software (OPUS) version 4.2 data
collection and analysis program. Two drops of sample were placed on a Real crystal IR KBr
card and air dried before determination of spectra. Transmission spectra were obtained after 16
background and 16 sample scans.
2.3

Results and Discussion

2.3.1

Minimum Inhibitory Concentrations

The lowest at which no growth was observed was 200ppm. Results are shown in Figure 2.1.
The fungus was tolerant at concentrations below 200ppm. Subsequent metabolism studies were
conducted at a concentration lower than this.
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2.3.2

Suitability of B3 Media

After a lag phase of two days, the fungi grew at a fast rate, steadily increasing in mycelia mass
until the 14th day. Growth rates are compared in Figures 2.2a and 2.2b. The mean increase in
mycelia weight after 14 days for the two types of media found not to be different (p=0.1,df=13)
in a paired t-test.

1(c) 5 ppm

1(b) Solvent only

1(a) Agar only

1(f) 40ppm

1(d) 10 ppm

1(i) 150ppm

1(h) 120ppm

1(g) 80ppm

1(e) 20ppm

1(j) 200ppm

Figure 2.1. MICs for tebuconazole against T. harzianum.
Growth in B3 did not differ from that in malt extract broth recommended for molds. B3 was
appropriate for use in further tests. B3 was preferred for further experiments because with Nlimitation, it represents more of the situation in wood and has no proteins which would have
interfered with further work on proteineous extracts produced by the fungi.
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Figure 2.2a. Growth in B3 media.

Fig 2.2b. Growth in malt extract broth.
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2.3.3

Quantitative Analysis of Degradation of Tebuconazole

After 6 days, it was apparent that tebuconazole amount in media inoculated with fungi was
reducing at a steady rate. After 21 days, 68.2% of the original 20ppm was depleted. The actual
values retained are shown in Figure 2.3. Less than 10% was depleted in control cultures.
Control(No fungi)

With Fungi

Tebuconazole (ppm)

25
20
15
10
5
0
0

3

6

9

12

15

18

21

(Days)

Figure 2.3. Tebuconazole retained in media after 21 days.
2.3.4

Quantitative Analysis of Tebuconazole Absorbed on Mycelia

Analysis of tebuconazole absorbed on fungal mycelia revealed that only 0.09ppm (<1%) was
extracted by 100mls of methanol. This minute amount led to the conclusion that adsorption of
the chemical on the surface of the microbial cells or assimilation into the cell for immobilization
are not the mechanisms employed by this species in tolerating tebuconazole.
2.3.5

HPLC Analysis

Secondary metabolites produced by T. harzianum did not affect the analysis of tebuconazole.
Chromatograms of the standard, test tebuconazole in media only (culture control), and test
tebuconazole in media exposed to fungi for 21 days are compared in Figure 2.4. Parent
tebuconazole eluted at 28 min. Major components of the media eluted at 5 and 21 min. Eluting
compounds thought to be metabolites were those not found in the media and eluting at times
different from tebuconazole. Four fractions with metabolites (M1, M2, M3, and M4) were
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identified and collected. Their retention times were 3.8, 9.1, 16, and 34 min. respectively. Three
metabolites were more hydrophilic than tebuconazole and eluted from the column faster than
tebuconazole. One metabolite eluted after tebuconazole.

0 5.0

10.0

15.0

20.0
25.0
Minutes

30.0

35.0

Figure 2.4. HPLC chromatograms.

2.3.6

Mass Spectral Characterizations

Intact molecular mass is not a unique identifier because different compounds may have the same
mass. However, determination of an intact molecular mass was useful in this case because a large
part of the molecule (tebuconazole) was already known and only a minor unknown change or
changes needed to be characterized. Molecular mass was measured to within an accuracy of 5 ppm.
The spectrum for parent tebuconazole showed the dominant ion at m/z 308.15, consistent with the
protonated molecular ions (M+H+). Figure 2.5a shows the mass spectra of the whole culture at
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beginning of incubation, and fraction 3 after 5 and 21 days incubation respectively. Results of all
other mass spectra are summarized in Table 2.1. Metabolites in HPLC fractions had intense peaks of
protonated ion (M+H+) at 338.34, 324.15, 281.17, and 366.36, for M1 to M4 respectively.

Fraction 3, 5 days
incubation

Fraction 3, 21 days
incubation

Rel. Intensity

Whole culture at
start of incubation

m/z, amu

m/z, amu

m/z, amu

Figure 2.5. Mass spectra of whole culture and fraction 3.
Each fraction may have had more than one compound, but only the major component identified by
MS is discussed. The others were in minute amounts and their structure could not be determined by
the method used in this study.
The number of possible chemical formulae assigned to an accurate determined mass was
reduced by comparing spectral and isotope patterns using the method by Stoll et al. (2006). The
35

Cl :37Cl, 3:1 intensity isotope pattern distribution was apparent and was used to identify actual

metabolites as opposed to those arising from the media or fungal secretions. Thus spectra were
used to rate and exclude compounds not resulting from the metabolism of tebuconazole. The
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intensity ratios in the isotopes are due to the natural abundance of the isotopes. Tebuconazole
and all four metabolites had the 3:1 intensity isotope pattern. Figure 2.6 shows this pattern in
tebuconazole and metabolite M3. There is a possibility that metabolites without Cl remained
unidentified.
Table 2.2. Summary of positive ESI-MS spectra - dominant ions and intensities
Sample
Tebuconazol standard

Fraction 1

Fraction 2

Fraction 3

Fraction 4

Media blank

Peaks (m/z, amu)
308.15
309.15
310.15
371.11
308.15
310.15
338.34
340.36
371.11
264.13
308.15
310.15
324.33
326.32
312.15
371.11
281.17
283.18
308.15
265.17
371.10
281.17
324.15
308.17
364.36
366.37
368.35
371.11
371.21
121.97
131.96

Intensity counts (%)
100
10
25
82
80
25
100
20
82
18
100
25
80
21
14
75
100
25
57
33
15
25
22
45
21
100
24
72
100
70
35

Most intense peaks
308.15

338.34, 308.15

324.15, 308.15

281.17

366.37

371.21
121.97

Based on the molecular mass and the reversed nitrogen rule since the molecular ions were
generated by protonation, an even mass for tebuconazol and three of the degradation products
indicated presence of an odd number of nitrogens (three). This led to the conclusion that these
degradation products contained the intact triazole ring. One product (M3) with a molecular mass
281.17 indicated an even number of nitrogens. These coupled with a loss of 27 amu, led to the
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conclusion that the HCN fragment was lost after cleavage of C-N and/or N-N bonds on the 1,2,3triazole ring to form an imine. Tebuconazol, M1, M2 and M4 all have a degree of unsaturation of
7 while M3 has 6 further confirming of the cleavage of the triazole ring. Two peaks
corresponding to 281.17 were observed in the TIC for M3. This corresponds to two possible
products of triazole cleavage at two different places both resulting in the loss of an H-C-N
fragment (Table 2.2).

Relative intensity (%)

100

(A. Tebuconazol
Standard)

(B. Metabolite 3)

50

0

Figure 2.6. Isotope distribution pattern in tebuconazole and M3
2.3.7

IR Analysis

Discovering the identity of each metabolite involved analysis of functional groups. Figure 2.6
shows the IR spectra of the four fractions. IR analysis of functional groups (Figure 2.7) revealed
no difference in relevant bands in the spectra of M3 and that of tebuconazole. Relevant bands in
the IR spectra for M1 and M2 showed presence of the carboxylic acid and hydroxyl groups in the
molecule. Most likely these compounds are the primary oxidation products of the methyl groups
on the tert butyl moiety, i.e., the hydroxyl and the carboxyl. Table 2.3 presents a summary of
relevant bands observed in IR spectra and change in molecular mass in the protonated ion.
Within 21 days, 68.2% tebuconazole was metabolized by T. harzianum into a form that
may be less toxic thus enabling the fungi to grow. Less than 1% was absorbed on the mycelia.
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Hence adsorption of the chemical on the surface of the microbial cells or assimilation into the
cell for immobilization were not the mechanisms employed by this species in tolerating
tebuconazole. The combination of MS and FTIR reveals that in addition to cleavage of the
triazole ring, this mold performs oxidation reactions as a prelude to the detoxification of
tebuconazole as is common with other biocides (Kanaly and Harayama 2000; Kelley et al. 1993).
Table 2.3. Summary of change in molecular mass and relevant IR bands
Protonated ion
mass (M+H)+
308.15

Change
in amu
0

Unique IR
band observed
-

Proposed
pathway

324.15

+16

3200-3000

Oxidation

338.34

+30

3500-2500

1. Oxidation

1700-1800

2. Carboxylation

1700-1800

1. Oxidation

(Tebuconazol)

366.37

+58

2. Acetylation.
281.17

-27

-

Triazole ring cleavage

The products resulted from the oxidation of the methyl groups on the tert butyl moiety, (i.e., the
alcohol and the carboxylic acid readily identified by the sharp C=O stretch between 1680 and
1725 cm−1) and the O-H stretch of the carboxylic group appearing as a broad peak in the 25003000 cm−1 region. Oxidation may also have occurred on the phenyl ring, and at α –carbon. In
contrast with the work of Strickland et al. (2004), there was no evidence of dechlorination or
oxidative cleavage of the phenyl ring. Cleavage of the 1,2,4 triazole ring is most likely the major
pathway for detoxifying tebuconazole. It is through binding of the triazole to the heme of the
cytochrome P-450 enzyme sterol 14α demethylase that ergosterol synthesis is inhibited thus
retarding growth of the fungi. Once the triazole ring is broken down, this mechanism is
interfered with. Monooxygenase type reactions were shown to occur in agreement with the work
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Figure 2.7. IR spectra of tebuconazole and fractions
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of Strickland et al. (2004). Oxidation metabolites identified are likely not the final products.

Many fungi after initial oxidation perform phase II reactions in detoxification of xenobiotics.
M1

Tebuconazole

Wavenumber cm-1

1000
500

M3

500

Conjugation (methylation, glucosidation, acetylation and sulphonation) are thought to be
reactions used by fungi in metabolizing chemicals to non toxic metabolites (Cerniglia et al.
1982). These results showed that T. harzianum further metabolizes the hydroxyl group formed
on the tert butyl moiety by acetylation to form an ester corresponding to the intense strong band
in the 1670-1700 cm-1 double bond region in M4 and a corresponding increase in molecular mass
(Table 2.2). Acetylation deactivates the chemical or its phase 1 metabolite and results in a less
hydrophilic product (Cerniglia et al. 1982). No evidence of glucosidation and sulphonation was
observed. However, there is a possibility that they occurred. Sulphonation would be evidenced
by IR absorption at 700-900cm-1 indicating the presence of S-OR. However this absorption is
also evidence of a C-Cl bond, present in tebuconazole and all metabolites. Fungi can perform
many different complex conversions of polyaromatic hydrocarbons and steroid compounds.
Biochemical evidence indicates that such bioconversions are often mediated by cytochrome
P450 (P450) as a part of monooxygenase enzyme systems. P450s are a family of hemoproteins
acting in many organisms ranging from bacteria, fungi, to mammals. They catalyze
monooxygenation of a wide variety of endogenous and exogenous compounds. The
monooxygenase systems are multicomponent, consisting of P450 and an electron donating
system, needed for the oxygen insertion in the substrate molecule (Makovec and Breskvar,
2000). The most common reaction catalysed by P450 is a monooxygenase reaction (i.e.,
insertion of one atom of oxygen into an organic substrate (RH) while the other oxygen atom is
reduced to water in a phase I type reaction). Although the presence of P450 was not confirmed
in this study, monooxygenase type reactions were shown to extensively occur. Based on MS, IR
spectra and isotope pattern the proposed metabolic pathway for transformation of tebuconazole is
shown in Figure 2.8.
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Figure 2.8. Proposed metabolic pathway of tebuconazole by T. harzianum (fraction numbers
in parentheses)
Intervention mechanisms to stabilize or increase the durability of tebuconazole in treated timber
would likely involve use of an additive that acts as an inhibitor to the initial reactions. Further
work will involve identification of P450 in culture filtrates using spectral properties and
occurrence of phase II type reactions which are thought to be used by the fungi in excretion or
tolerance of tebuconazole. Since the initial oxidative reactions are mediated by P450, a suitable
additive to tebuconazole would be one that is an inhibitor of P450. The chemical inhibitors must
be specific toward cytochrome P450-mediated reactions in fungi. Several compounds that have
an inhibitory effect on P-450 monooxygenases are known and may be of use. An example is
piperonyl butoxide (PB). PB can act as a pesticide synergist. Although it does not have
pesticidal properties, when added to a wood preservative mixture, its efficacy will be increased
because the principal detoxification pathway (monooxygenation) is inhibited. Prevention or
decrease in the rate of the initial oxidation will ensure the phase II reactions such as acetylation
and methylation do not occur. EDTA (ethylenediamine tetraacetic acid) is an amino acid and
chelating agent widely used to sequester di- and trivalent metal ions. EDTA may inhibit mono
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oxygenation by chelating Fe3+ and Fe2+ ions important the P450 cycle. EDTA binds to metals
via four carboxylate and two amine groups. Inhibiting the detoxification pathway allows higher
unmetabolised systemic concentrations of the active insecticide to remain within the timber for a
longer period.
The method used in this study was not able to identify more metabolites due to low
concentrations, interference of media components and the complex pattern of IR peaks below
1500 cm-1 which are difficult to assign. Using radio active labeled 3H of 14C tebuconazole would
give a more complete picture of all types of metabolites and pathways involved.
2.4

Conclusions

T. harzianum is able to tolerate tebuconazole at concentrations below 200ppm because it
biotransforms the chemical mainly by cleavage of the 1, 2, 4 triazole ring and oxidation reactions
to produce more hydrophilic metabolites. The tert butyl alcohol, the tert butyl carboxylic acid,
and are the initial products. These initial oxidation products undergo acetylation or in a second
step resulting in less hydrophilic metabolites. Mold fungi are able to tolerate tebuconazole by
this mechanism. However, biotransformation may not be the only mechanism employed by T.
harzianum in tolerating tebuconazole.
2.5
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CHAPTER 3. BIOTRANSFORMATION OF TEBUCONAZOLE BY BACTERIA AND
FUNGI: A COMMON MECHANISM?
3.1.

Introduction

The trend towards the use of environmentally sound building materials has increased the interest
in wood preservation based on boron and purely organic systems. Much attention is being
directed towards the formulation and testing of metal-free preservative systems. Organic
biocides will play an increasing role in all user classes in the future (Schultz and Nicholas, 2006).
Currently, the major advantage of organic systems is also their major disadvantage: their
biotransformation by wood degrading and wood inhabiting but non-degrading microorganisms.
Other missing elements in the organic systems are photoprotection and hydrophobicity (Evans,
2003). Microbial mediated detoxification of biocides may contribute significantly to the failure
of treated wood (Briscoe et al., 1990).
Intricate groups of highly diverse microorganisms living in close association may be
found in wood that has been exposed to the atmosphere or the soil for a long period of time. Any
of the microorganisms present, including non-wood destroying organisms may be capable of
biotransformation of chemicals at a faster rate than observed in laboratory studies (Briscoe et al.,
1990). One species may modify the environment often making an otherwise unsuitable
environment suitable to another micro-organism. Wood-inhabiting fungi, not necessarily
responsible for major decay, have been shown to be capable of degrading a toxic compound or
metabolizing it into a less potent form or derivative, thus, rendering it less effective in protecting
wood from decay by typical wood-destroying fungi, which are less-tolerant basidiomycete wooddestroyers (Duncan and Deverall, 1964; Ruddick, 1984). A study of the biodetoxification of 3Benzo[b]thien-2-yl-5, 6-dihydro-1, 4, 2-oxathiazine-4-oxide) isolated 11 species of
proteobacteria that showed the ability to degrade the biocide (Wallace and Dickinson, 2004).
Bacteria cause reductions in biocide concentrations ranging from 14% for 2-thiocyanomethylthio
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benzothiazole (TCMTB) to nearly 65% in MBT (Briscoe et al., 1990). Through HPLC and a
bioassay, Wallace and Dickinson (2006) demonstrated that tebuconazole, chlorothalonil, and
IPBC are detoxified when exposed to the Rastolia strain of bacteria. No degradation products
were isolated. Wood-destroying basidiomycetes that secrete the enzyme laccase into the culture
medium are able to overcome the toxic effects of pentachlorophenol (PCP) (Lyr, 1963).
Increases in both threshold and toxic limits have been observed when wood treated with
alkylammonium compounds is first subjected to staining fungi and then basiodiomycetes in a
second step (Ruddick, 1984). Gliocladium roseum is a mold that is capable of transforming
significant amounts of DDAC (didecyldimethylammonium chloride). In one study nearly 50%
of the DDAC in sawdust was degraded over 11 weeks (Dubois and Ruddick, 1998). It was
hypothesized that the alteration of the quat compounds by the mold may detoxify them to a level
where wood rotting basidiomycetes could grow. The metabolite was identified as a hydroxylated
quaternary ammonium compound (QAC). Phanerochaete chrysosporium is recognized for its
ability to metabolize a large diversity of compounds, including PCP, by the lignin degrading
system (Mendoza-Cantu et al., 2000). M. incrassata has been reported to tolerate chromated
copper arsenate (CCA) and cause substantial weight loss in pine blocks treated with CCA or
copper sulphate (Illman and Highley, 1996). Trichoderma harzianum is known to be tolerant to
the anti-sapstain methylene-bis –thiocyanate (MBT) at concentrations ranging from 4ppm to
34ppm and most fungicides. Considerable increases in threshold and toxic limits have been
observed when wood treated with alkylammonium compounds is first subjected to T. harzianum
and then basidiomycetes in a second step. Trichoderma spp. are present in nearly all soils and
other diverse habitats.
The effects of bacteria have long been recognized as the ability to cause pronounced
increase in permeability and more recently their ability to degrade preservative treated wood and
highly durable timbers containing high extractive levels (e.g., Eusideroxylon zwageri) and
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timbers high lignin contents (e.g., Alstonia scholaris) (Daniel, 2003). The role of bacteria in the
degradation of organic preservatives is important when considering the long term performance
expected from treated wood in service. Activity against the causal decay organisms and
resistance to physical losses are no longer the sole performance criteria that need to be
understood when developing new wood preservatives. Despite the role played by
microorganisms in wood degradation or preservative detoxification, they are not normally
considered in biocide evaluation. As the wood preservative industry becomes more reliant on
wholly organic fungicides, there is a need to establish biotransformation pathways of biocides
and use this knowledge to attempt to stabilize them in wood by disruption of the detoxification
process. An understanding of mechanisms involved in detoxification by bacteria, fungi, and
termites is needed to provide means for defeating these processes (Wallace and Dickinson,
2006).
In the current study one bacteria strain (Pseudomonas fluorescens), a mold fungus (T.
harzianum), a white rot fungus (P. chrysosporium) and a brown rot fungus (M. incrassata) were
used to access the extend of biodegradation and the initial products of metabolism of
tebuconazole. This study proposes the mechanism(s) for the metabolism and explores the
possibility of a common biotransformation mechanism for all species studied. If it proves
possible to disrupt the mechanism of degradation, this could herald a new generation of
environmentally friendly wood-preservatives.
3.2

Materials and Methods

3.2.1

Test Chemicals and Fungi

Ninety five percent tebuconazole (Preventol A8) was provided by Lanxess Corporation
(Pittsburgh, PA) and the standard (99%) was obtained from Sigma Aldrich (St Louis, MO). An
original freeze-dried strain of the bacteria species (ATCC No. 11150) was obtained from the
American Type Culture Collection (Manassas, VA). All fungal species were provided by the
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US. Forest Products Laboratory (Madison, WI). Fungal cultures were grown out and
maintained on media containing 1.5% agar, 2% malt extract, and 0.001% yeast extract.
3.2.2

Determination of MICs

Preliminary work involved determination of the minimal inhibition concentrations (MIC) for
tebuconazole against P. chrysosporium and M. incrassata. The MIC of T. harzianum had been
determined in a prior study (Chapter 2). Plates of nutrient agar containing tebuconazole in
concentrations ranging from zero (control) to 200ppm were prepared in triplicate. Plates were
kept at 25oC for 14 days. MIC the lowest concentration at which no visible growth of mycelium
was observed was determined.
3.2.3

B3 Media Suitability

The study utilized nutrient limited B3 medium for N-limitation. B3 represents a more
applicable situation for wood which has low amounts of nitrogen. B3 media per liter of distilled
water contained: 1.73 t-aconitic acid adjusted to pH to 4.5 with KOH, 2g KH2PO4, 0.5g
MgSO4.7H2O, 0.1g CaCl2.2H2O, 0.2g ammonium tartrate, 10g glucose, 0.001g thiamine and
10mls mineral elixir. Mineral elixir contained the following per liter: 1.5 g nitrilotriacetic acid
(pH adjusted to 6.5 with KOH, 3.0g MgSO4.7H20, 0.5g MnSO4.H2O, 1.0g NaCl, 0.1g
FeSO4.7H2O, 0.1g CoSO4, 0.1g CaCl2, 0.1g ZnSO4.7H2O, 0.01g CuSO4, 0.01g
AlK(SO4)2.12H2O, 0.01g H3BO3, and 0.01g NaMoO4.2H2O. Because B3 media was studied
and developed specifically for P. chrysosporium’s extracellular peroxidase production, it was
necessary to ascertain its suitability for growing M. incrassata in subsequent degradation studies.
One circular plug obtained from 8-day old cultures of M. incrassata and 12-day cultures of P.
chrysosporium was used to inoculate 100mls of sterilized B3 in Erlenmeyer flasks. Twenty eight
flasks were inoculated for each species, covered with parafilm, and kept at 25oC for two weeks
on a shaker at 100rpm. Growth was monitored by weighing the dry fungal cell mass harvested
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by filtering the liquids through Whatman #2 filter paper at time intervals of 0-14 days. Mycelia
were rinsed twice with deionized water and air dried to constant weight. Separate flasks were
grown using malt extract broth as growth media. The broth contained 17g/l of mycological
peptone and 3 g/l of malt extract. Growth rates for the two media were compared after 14 days.
3.2.4

Biotransformation Studies

Two hundred and fifty ml. Erlenmeyer flasks containing 100ml B3 media were supplemented
with 0.1ml of 0.02% tebuconazole to give a final concentration of 2 ppm for each flask. Flasks
were inoculated with an agar plug from actively growing colonies. Cultures were incubated at
25oC and shaken at 120rpm for a period ranging from 3-21days. Three replicates were used for
each time interval. For the bacteria strain, 250 ml flasks containing 50 ml Luria Bertani (LB)
media were supplemented with 0.1ml of 0.2% tebuconazole to make 20ppm of each solution.
An overnight P. fluorescens culture (100µl) was added and flasks were incubated at 30oC and
shaken at 120rpm for a total of 21 days. LB Media contained: 10.0 g/l tryptone, 5.0 g/l yeast
extract, and 5.0 g/l NaCl. All samples were centrifuged (10 min. at 15000xg and 4oC). The
centrifuge was a fixed angle rotor, induction drive Beckman model J2-21M. The culture controls
consisted of media blanks in which microorganisms were grown under identical conditions in
media but without tebuconazole. The substrate control consisted of tebuconazole and sterile
media incubated without innoculum to determine whether tebuconazole could chemically
decompose or transform under experimental conditions.
3.2.5

Quantitative Determination of Tebuconazole Retained in Samples

Five ml of filtered medium was extracted in solid-phase extraction (SPE) columns. The columns
(Bond Elut –C18, 500mg, 3ml Varian #12102028) were preconditioned with two column
volumes of methanol, followed by two column volumes of milli-Q water. Five ml of sample was
loaded and pulled through at one drop per second, followed by a column rinse of 50:50
acetonitrile water. Retained compounds were eluted with 4 column volumes of methanol
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collecting in 15ml centrifuge tubes. Each tube was dried to below 5ml on a nitrogen evaporator
and transferred to a second tube while passing over sodium sulfate. The final volume was
adjusted to 5ml. Samples were cleaned with a 0.2 µm Teflon™ filter prior to quantitative
analysis by gas chromatography (GC-MS). The GC-MS was an Agilent 6890 gas
chromatograph using a 5973 mass selective detector. The injection port temperature was 250oC,
the detector temperature 280oC, and the carrier gas was helium at 1 mm min-1. The oven was
initially held at 80oC for 2 min followed by a 30oC min-1 increase to 190oC and then an 8oC min-1
increase to a final temperature of 300oC. The capillary column model No. RTX35 was 30m X
250µmX 0.25µm. Injection volume was 2.0µl, and total run time was 20.42 minutes.
Tebuconazole eluted at 15.9 min. Running in selected ion mode (SIM), ions detected for
tebuconazole were 250 as the target ion, and 125 and 252 as the qualifier ions. Calibration was
done using a four point curve. Concentrations of the samples were calculated using the formula:
(X / V1)* (V2)*dilution factor
Where:

[1]

X - off the curve reading from the instrument.
V1- Initial vol. of sample extracted by SPE.
V2- final vol. of sample after SPE.

3.2.6

Preparation of Samples for HPLC

To isolate the major metabolites in sufficient quantities for structural elucidation, the
transformation of tebuconazole was carried out on a preparative scale. For each fungal species,
ten 250ml Erlenmeyer flasks containing 100ml of B3 media were supplemented with 0.1ml of
0.02% tebuconazole to give a final concentration of 2 ppm. Flasks were inoculated with an agar
plug from an actively growing colony, incubated at 25oC, shaken at 100rpm for 21 days, and
centrifuged (10 min. at 15000xg and 4oC). The liquid samples were pooled into two equal
composite samples. For the bacteria, ten 250 ml flasks containing 100 ml. Luria Bertani (LB)
media were supplemeted with 0.1ml. of 0.2% tebucanazole to make 20ppm of each solution. An
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overnight P. fluorescens culture (100µl) was added and flasks were incubated at 30oC while
shaking at 120rpm for 21 days. Samples were then centrifuged (10 min. at 15000xg and 4oC)
and filtered and pooled into two equal composite samples.
Each sample was subjected to extraction and cleanup by the following procedure: The
sample was transferred into a 1L separating funnel to which 75ml of dichloromethane was
added. The sample was subjected to shaking for 1.5 min. vented every 20 seconds to release
pressure, then left to stand for 3 min. The bottom layer was passed over sodium sulfate into a
400ml beaker. Extraction was repeated twice. The sample was then placed on a water bath at
45oC and evaporated until almost dry. Five ml of acetonitrile was added for solvent exchange,
re-dried to about 2ml, and transferred to a centrifuge tube with several rinses of acetonitrile while
passing over sodium sulfate. The tube was dried to below 5ml. on a nitrogen evaporator, the
final volume adjusted to 5ml before qualitative analysis by high pressure liquid chromatography
(HPLC). The culture controls consisted of blanks in which microorganisms were grown without
tebuconazole. The substrate control consisted of tebuconazole and sterile media without fungi.
3.2.7

HPLC Analysis

Several reverse-phase HPLC runs were necessary to detect and purify metabolites. The system
consisted of a Waters 600 pump with a Waters 2487 UV detector. The column was a Waters
Delta-Pak C18, 300 Å, 15 micron, 8mm x 10 cm radial compression module. Eluant
composition as a function of time was: isocratic from 0-5 min. 70% water+ 0.1% formic acid
30% acetonitrile, linear increases of acetonitrile from 5-30 min. to 85%, and isocratic at 85%
acetonitrile for 5 min. Flow rate was 1 ml min.-1 and detection was at 224 nm wavelength.
Tebuconazole eluted at 28 min. Qualitative analysis using authentic standards of metabolites
was not possible as metabolites of tebuconazole could not be obtained. Tebuconazole peaks and
those of metabolites were identified by comparison of elution time, protonated molecular mass,
isotopic pattern distribution, and identification of functional groups in the tebuconazole standard,
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media containing tebuconazole before exposure to microorganisms and in media containing
tebuconazole after exposure to microorganisms
3.2.8

Mass Spectral Characterizations and IR Analysis

Exact mass determination of HPLC fractions of tebuconazole and its metabolites was performed
by electrospray ionization (ESI). The instrument operated in positive ESI mode was an Agilent
6210 Time of flight (TOF) LC/MS mass spectrometer. HPLC fractions and authentic
tebuconazole were subjected to IR analysis to determine functional groups retained or changed
on the metabolites. The FTIR system was a Bruker Tensor 27 system single beam instrument
connected to an optical user software (OPUS) version 4.2 data collection and analysis program.
Two drops of sample were placed on a Real crystal IR KBr card and air dried to dryness.
Spectra were determined after 16 background and sample scans.
3.3

Results and Discussion

All results of this study were analyzed and compared to those for T. harzianum carried out in the
previous study (Chapter 2).
3.3.1

Minimum Inhibitory Concentrations

Of the concentrations tested, the lowest at which no growth was observed was 20ppm for M.
incrassata and 5ppm for P. chrysosporium. Mycelia diameter increases on Petri dishes and
MICs are shown in Table 3.1.
3.3.2

Suitability of B3 media for M. incrassata.

After a lag phase of 7 days, M. incrassata grew at a fast rate, steadily increasing in mycelia mass
until the 21st day. The mean increase in weight of fungal mycelia after 21 days for the two types
of media were compared in a paired t-test and found not to be different (p=0.12, df=13).
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Table 3.1 Diameter increase* (mm) and MICs of the fungi tested.
Tebuconazole (ppm)

M. incrassata

P. chrysosporium

T. harzianum

Agar only (control)
0 (solvent- acetone)
0.5
1
1.5
2
2.5
5
10
15
20
25
50
80
100
150
180
200
MIC

76
76
76
66
44
38
36
24
18
6
0
0

76
76
68
10
5
4
2
0
0

20

2.5

76
76
76
76
76
76
76
76
76
70
70
64
42
38
38
10
5
0
200

* Diameter increase = [(Diameter of mycelia –Diameter of the original plug (10mm)]

Growth in B3 media did not differ from growth in malt extract broth. Hence B3 media was
appropriate for use in further tests. B3, media was preferred for further experiments because it
does not contain proteins that would have interfered with further work on proteineous extracts
produced by the fungi. Figure 3.1 shows growth of the fungi in the two types of media.

0.45
0.4

0.4

0.35

0.35

0.3

0.3

Weight (g)

Weight (g)

y = -0.0005x 2 + 0.03x + 0.029
R2 = 0.95

0.45
y = -0.0005x2 + 0.029x + 0.025
R2 = 0.96

0.25
0.2
0.15

0.25
0.2
0.15

0.1

0.1

0.05

0.05

0

0
0

5

10

15

20

25

0

Days

Figure 3.1a. Growth of M. incrassata in B3 media

5

10

15

20

25

Days

Fig 3.1b. Growth of M. incrassata in malt extract
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3.3.3

Quantitative Analysis of Degradation of Tebuconazole

After 12 days, it was apparent that the amount of tebuconazole in media inoculated with bacteria
and M. incrassata was reducing at a steady rate. After 21 days, 70.2% was depleted by bacteria
from the LB media. In B3 media, 40.4% was depleted by M. incrassata while 4.1% was
depleted by P. chrysosporium. Actual values retained are shown in Figure 3.2. The control
cultures had less than 5% of the tebuconazole depleted. The average amount depleted in control
cultures and in P. chrysosporium cultures were not significantly different (P=0.1, df =5). Hence
tebuconazole degraded over 21 days in P. chrysosporium cultures was insignificant.
Control

With bacteria

25

Tebuconazole (ppm)

20
15

Bacteria
(P. fluorescens)

10
5
0
0

3

6

9

12

15

18

21

Days

Control

With fungi

Tebuconazole (ppm)

2.5
2
1.5

White rot
(P. chrysosporium)

1
0.5
0
0

3

6

9

12

15

18

21

Days

Control

With fungi

Tebuconazole (ppm)

2.5
2

Brown rot
(M. incrassata)

1.5
1
0.5
0
0

3

6

9

12

15

18

21

Days

Figure 3.2. Tebuconazole retained in media after 21 days.
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3.3.4

HPLC Analysis

Secondary metabolites produced by microorganisms did not affect the analysis of tebuconazole.
Two major metabolites were eluted and isolated in cultures of M. incrassata and two in cultures
of P. fluorescens in addition to tebuconazole. These metabolites were not found in control
cultures. Chromatograms of P. chrysosporium cultures contained mainly tebuconazole.
Chromatograms of the standard, substrate control and culture control, and test tebuconazole in
media exposed to fungi or bacteria for 21 days were obtained and compared. Chromatograms
are shown in Figure 3.3 and 3.4. Parent tebuconazole eluted at 28 min. Major components of B3
media eluted at 2 and 21 min. Major components of Luria Bertani media eluted at 5 and 21 min.
Compounds thought to be metabolites were those not found in the media and eluting at times
different from that of tebuconazole. Metabolites of M. incrassata had retention times of 15 and
17 min. and those for Pseudomonas fluorescens had retention times 15 and 11 min., respectively.
All the metabolites were more hydrophilic and eluted from the column faster than tebuconazole.

Culture control
(no bacteria)

With bacteria

Figure 3.3. HPLC Chromatograms after exposure to bacteria.
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Figure 3.4. HPLC chromatograms after exposure to fungi.
3.3.5

Mass Spectral Characterizations and IR Analysis

Intact molecular mass of a compound is not a unique identifier because some compounds may
have the same intact mass. However, determination of exact intact molecular mass was useful in
this case because a large part of the molecule (tebuconazole) was already known and a minor
unknown change or changes needed to be characterized. The Agilent 6210 Time of flight (TOF)
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mass spectrometer used had high accuracy of 2 ppm mass dependent The number of possible
chemical formulae assigned to an accurate determined mass was reduced by comparing spectral
and isotope patterns based on mass measurement obtained using the method by Stoll et al.
(2006). Thus, spectra were used to rate and exclude compounds not resulting from metabolism
of tebuconazole. Parent tebuconazole showed a protonated mass (M+H)+of 308.15. A summary
of the spectra monitoring intense peaks of fractions and comparing them with results of T.
harzianum from chapter 2 are shown in Table 3.2.

Fraction 2, bacteria
culture

Rel. Intensity

Fraction 2, M. Incrassata

m/z, amu

m/z, amu

Figure 3.5. Spectra of fractions
The 35Cl:37Cl 3:1 intensity isotope pattern distribution shown in Figure 3.6 was apparent because
of the chlorine on tebuconazole and was used to identify actual metabolites as opposed to those
arising from the media or fungal secretions. Intensity ratios in the isotope are due to the natural
abundance of the isotopes.
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Table 3.2. Summary of positive ESI-MS m/z spectra - dominant ions and intensities
Sample
Tebuconazol standard

P. fluorescens

Fraction 1

Fraction 2

M. Incrassata

Fraction 1

Fraction 2

P. chrysosporium

No major
fraction
identified

T. harzianum

Fraction 1

Fraction 2

Fraction 3

Fraction 4

Media blank

Peaks (m/z, amu)
308.15
309.15
310.15
371.11
308.15
310.15
324.16
326.19
371.11
308.15
306.35
281.17
283.19
371.11
308.15
324.16
338.34
340.36
371.11
264.13
281.17
283.18
308.15
265.17
371.10
308.15
309.15
310.15
324.17
371.11
308.15
310.15
338.34
340.36
371.11
308.15
324.33
326.32
371.11
281.17
283.18
308.15
265.17
371.10
281.17
308.17
364.36
366.37
368.35
371.11
371.21
121.97
131.96
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Intensity counts (%)
100
10
25
82
80
25
100
28
82
20
10
100
24
21
20
20
100
23
82
18
100
25
57
33
15
100
10
24
34
53
80
25
100
20
82
45
80
21
75
100
25
57
33
15
25
45
21
100
24
72
100
70
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Most intense peaks
308.15

324.16, 308.15

281.17, 308.15

338.34, 308.15

281.17

308.15

338.34, 308.15

324.15, 308.15

281.17

366.37

371.21
121.97

100

Relative intensity (%)

(A. Tebuconazol
Standard)

(A. Metabolite 1
bacteria culture)

(B. Metabolite 2
bacteria culture)

50

0

Figure 3.6. Tebuconazole and metabolite isotope distribution pattern.
Within 21 days, 40.4% and 70.2% of tebuconazole was metabolized by M. incrassata and
Pseudomonas fluorescens respectively, into a form that may be less toxic. Although P.
chrysosporium, is recognized for its ability to metabolize a large diversity of compounds,
including pentachlorophenol (PCP), by the lignin degrading system (Kullman and Matsumura,
1996; Sack et al., 1997; Mendoza-Cantu et al., 2000) it showed little or no ability to metabolize
tebuconazole. Little degradation occurred over the exposure period of 24 days. This collaborates
the results of Morrell and Velicheti (1994) who showed that P. chrysosporium was not able to
degrade triazoles to a significant or measurable amount.
Establishing the identity of metabolites in the bacterial and M. incrassata cultures
involved analysis of functional groups. Figure 3.6 shows the IR spectra of the 2 HPLC fractions
from M. incrassata culture and the two fractions of the bacterial culture. Changes in protonated
mass and IR spectra, indicated that these two species degraded tebuconazole by cleaving the
triazole ring and also by oxidation reactions. Based on the reversed nitrogen rule since the
molecular ions were generated by protonation, an even mass for tebuconazole and some of the
degradation products indicated presence of an odd number of nitrogens (three). This led to the
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conclusion that these degradation products contained the intact triazole ring. One product in
fraction 2 of both M. incrassata and the bacteria culture had a molecular mass 281.17 indicating
an even number of nitrogens. These coupled with a loss of 27 amu, led to the conclusion that the
H-C-N fragment was lost after cleavage of C-N and/or N-N bonds on the 1,2,3-triazole ring to
form an imine. Tebuconazol has a degree of unsaturation of 7 while this metabolite has 6 further
confirming the cleavage of the triazole ring. Two peaks corresponding to 281.17 were observed
in the total ion count spectra of the fraction containing this metabolite. This indicates two
possible products of the same molecular mass after cleavage of the triazole ring at two different
places both resulting in the loss of an H-C-N fragment. This same metabolite was also observed
in T. harzianum cultures in (Chapter 2). This is evidence of a common mechanism in all fungal
species and the bacterium studied.
Oxidation of the tert butyl group was a major metabolic pathway in both species. The
main products were the oxidation of the methyl groups on the tert butyl moiety. Oxidation may
also have occurred on the phenyl ring and at the α–carbon. It was not possible to determine the
exact position of the hydroxyl group by the method used in this study. Previous results (Chapter
2) showed that the mold T. harzianum after initial oxidation reactions performs reactions similar
to phase II reactions (conjugation by acetylation) used in detoxification of xenobiotics in
mammalian systems. The fungus metabolizes the hydroxyl group formed on the tert butyl
moiety by acetylation to form an ester. Acetylation to form an ester was not observed in the
metabolism by M. incrassata and Pseudomonas fluorescens. No evidence of glucosidation and
sulphonation phase II reactions was observed. However, there is a possibility that they occured
after the initial oxidation. These other phase two reactions are thought to be reactions used by the
fungi in metabolizing chemicals to form non toxic metabolites such as (Cerniglia et al., 1982).
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There was no evidence of dechlorination. The chlorine atom was present in all metabolites. IR
absorption at 700-800cm-1 and 3:1 isotope pattern in mass spectra observed in all metabolites
.indicated a C-Cl bond in tebuconazole and all fractions. There was no evidence of Ndealkylation resulting in the free triazole ring or products resulting from further reaction of the
triazole ring. Table 3.3 gives a summary of the changes in molecular mass and relevant IR
bands identified therefore leading to the proposed structures of metabolites and pathways
To detoxification
Table 3.3. Summary of change in molecular mass and relevant IR band
Protonated ion mass

Change
amu

308.15 (Tebuconazol)

in Unique IR band Proposed
observed
pathway

0

-

324.15

+16

3200-3000

Oxidation

338.34

+30

3500-2500
1700-1800

1. Oxidation
2. Carboxylation

281.17

-27

-

Triazole ring cleavage

The proposed pathways for transformation of tebuconazole by Pseudomonas fluorescens and T.
harzianum are shown are shown in Figures 3.8 and 3.9 respectively.
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Figure 3.8. Proposed metabolic pathway by the bacteria Pseudomonas fluorescens
(molecular weights in parentheses).
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The ability of a fungus to degrade a biocide contributes to the efficacy of the biocide. P.
chrysosporium with the lowest MIC (highest tebuconazole efficacy) was found not able to
degrade tebuconazole while T. harzianum with the highest MIC (lowest efficacy) degrades
tebuconazole and tolerates it at concentrations less than 200ppm. While molds like T. harzianum
are not responsible for decay, they may modify the environment by lowering biocide
concentrations or metabolizing it into a less potent form or derivative making an otherwise
unsuitable environment suitable to a wood degrading another micro-organism. They therefore
render the biocide less effective in protecting wood from decay by typical wood-destroying fungi
which are less-tolerant basidiomycetous wood-destroyers.
Fungi can perform many different complex conversions of polyaromatic hydrocarbons
and steroid compounds. Biochemical evidence indicates that monooxygenation bioconversions
are often mediated by cytochrome P450 (P450) as a part of monooxygenase enzyme systems
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(Makovec and Breskvar, 2000). The presence of P450 was not confirmed in this study although
monooxygenase type reactions were shown to extensively occur in the transformation of
tebuconazole by T. harzianum, M. incrassata and the bacterium Pseudomonas fluorescens.
Because the initial detoxification pathway is the same in all species i.e., cleavage of
triazole ring and oxidation, intervention mechanisms to stabilize or increase the durability of
tebuconazole in treated timber would be the same. This would most likely involve use of an
additive that acts as an inhibitor to the initial oxidation reactions. The additive must be specific
toward cytochrome P450-mediated reactions. Several compounds that have an inhibitory effect
on P-450 monooxygenases are known and may be of use. Examples are piperonyl butoxide (PB)
and EDTA (ethylenediamine tetraacetic acid). PB is a pesticide synergist. Although it does not
have pesticidal properties, when added to a wood preservative mixture, its efficacy may be
increased because the principal detoxification pathway (monooxygenation) is inhibited.
Prevention or slow down in the rate of the initial oxidation will ensure the phase II reactions such
as acetylation and methylation do not occur. EDTA is an amino acid and chelating agent widely
used to sequester di- and trivalent metal ions. EDTA may inhibit mono oxygenation by chelating
Fe3+ and Fe2+ ions important in the P450 cycle.
More probable metabolites could not be separated completely with this method due to
low concentrations and interference of media components. Using radio active labeled 3H or 14C
tebuconazole would give a more complete picture of types of metabolites and pathways
involved.
3.4

Conclusions

Although P. chrysosporium, is recognized for its ability to metabolize a large diversity of
compounds, it showed little or no ability to metabolize tebuconazole. Only parent tebuconazole
eluted after an HPLC run of a 21 day culture. M. incrassata (brown rot), the mold T. harzianum,
and bacteria Pseudomonas fluorescens all cleaved the triazole ring and performed mainly
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oxidation processes in the initial degradation of tebuconazole. The main initial products are the
imines resulting from triazole cleavage and oxidation products of the methyl groups on the tert
butyl moiety (i.e., the alcohol and the carboxylic acid). T. harzianum was able to perform phase
II type reactions by acetylation. M. incrassata and the P. fluorescens bacteria did not metabolize
the chemical by acetylation. The ability of a fungus to degrade a biocide contributes to the
efficacy of the biocide against that species. P. chrysosporium with the lowest MIC (highest
efficacy) was found not able to degrade tebuconazole while T. harzianum with the highest MIC
(lowest efficacy) degrades tebuconazole and tolerates it at concentrations less than 200ppm.
Molds such as T. harzianum though not responsible for decay, may lower biocide concentrations
or metabolize it into a less potent derivative making the environment suitable to wood degrading
microorganisms.
3.5
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CHAPTER 4. PROTEINEOUS EXTRACELLULAR EXTRACTS INVOLVED IN
BIOTRANSFORMATION OF TEBUCONAZOLE BY WOOD
INHABITING MOLDS AND DECAY FUNGI
4.1

Introduction

Activity against the causal decay organisms and resistance to physical losses are no longer the
sole performance criteria that need to be understood when developing a new wood preservative.
Microbial mediated detoxification of biocides by bacteria and fungi may contribute significantly
to the failure of treated wood (Briscoe et al., 1990). Though not responsible for decay, molds,
sapstains and bacteria, may lower biocide concentrations or metabolize it into a less potent
derivative making the environment more suitable to wood degrading microorganisms.
In Chapter 2 and 3 it was shown that the mold Trichoderma harzianum, brown rot
Meruliporia incrassata, and the bacterial species Pseudomonas fluorescens metabolize
tebuconazole by performing oxidation processes in the initial stages. The main products are the
oxidation products of the methyl groups on the tert butyl moiety (i.e., the alcohol and the
carboxylic acid). In addition the 1,2,4 triazole ring is cleaved resulting in imines. The products
of the degradation of tebuconazole were identified and found to be the same for all three species
Basiodiomycetes which produce lignin peroxidases and laccases to degrade wood, have been
found capable of metabolizing biocides using these enzyme systems (Lyr, 1963; Mendoza-Cantu
et al., 2000). Because T. harzianum and bacteria species do not degrade lignin and cellulose,
they do not produce lignin peroxides, laccase, and manganese peroxides. It is hypothesiszed that
a phase I cytochrome P 450 (P450) monooxygenase system is responsible for the initial steps in
the degradation of tebuconazole. Oxidation reactions are characteristic P450 dependent. The
P450 super enzyme family metabolizes a wide range of chemicals and has been characterized at
the protein and gene levels in animals and higher plants and marine macroalgae (Plugmacher and
Sanderman, 1998; Makovec and Breskvar, 2000). P450 enzymes are able to incorporate one of
the two oxygen atoms of an O2 molecule into a broad variety of substrates with concomitant
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reduction of the other oxygen atom by two electrons to H2O. The most common reaction
catalyzed is monooxygenation, but a wide spectrum of reactions including N-oxidation,
sulfoxidation, epoxidation, N-, S-, and O-dealkylation, peroxidation, deamination, desulfuration,
and dehalogenation are catalysed (Bezalel et al., 1997; Hawkes et al., 2000). A few family
members can catalyze intramolecular transfer of an oxygen atom. The sequences of more than
2000 members of the P450 superfamily are known. In fungi, P450s are key players in ergosterol
biosynthesis, and they are involved in pathogenesis by detoxifying host plant defenses.
Consequently, fungal CYP51 (lanosterol 14α-demethylase) is the primary target of antifungal
triazole drugs. Bacterial P450s participate in antibiotic synthesis and catabolic reactions. P450s
utilize NADPH as the electron donor of the monooxygenation reactions. Sterols are essential
constituents of the plasma membrane of all eukaryotic cells, and CYP51 is the most ancient form
of all eukaryotic P450s (Makovec and Breskvar, 2000).
This chapter reports on the characterization of the oxidizing enzyme of T. harzianum and
M. incrassata from culture preparations. So far, studies of P450s in fungi have been few
because of problems in the isolation of active enzymes including their low concentration in some
species (Uzura, 2001; Plugmacher and Sanderman, 1998). The B3 fungal culture used initially
contained no protein (N- limited). Therefore, increases in the amount of protein in the culture
gave an indication of proteineous extracts released by the fungi leading to subsequent isolation
and characterization. An understanding of enzymatic mechanisms may make it possible to arrive
at intervention strategies to increases the service life of wood treated with triazoles.
4.2

Materials and Methods

4.2.1

Test Chemicals

Ninety five percent tebuconazole (Preventol A 8) was provided by Lanxess Corporation
(Pittsburgh, PA) and the standard (99%) was obtained from Sigma Aldrich (St Louis, MO). All
fungal species were provided by the US. Forest Products Laboratory (Madison, WI). Fungal
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cultures were grown out and maintained on medium containing 1.5% agar, 2% malt extract,
0.001% yeast extract. NADPH (nicotinamide adenine dinucleotide phosphate). ABT (1aminobenzotriazole), piperonyl butoxide, and phenobarbital were obtained from Fisher Scientific
(Waltham, MA).
4.2.2

Growing Fungi and Preparation of Cell Extracts

For T. harzianum, 250ml Erlenmeyer flasks containing 100ml B3 media were supplemented with
0.1ml of 0.2% tebuconazole to give a final concentration of 20 ppm of each flask. Flasks were
inoculated with an agar plug from actively growing colonies. Cultures were incubated at 25oC
and shaken at 120rpm for a period ranging from 3-21days. Three replicates were used for each
time interval. For the white rot and brown rot cultures, 2ppm of tebuconazole was used. The
culture controls consisted of media blanks in which microorganisms were grown under identical
conditions in media but without tebuconazole. For P. chrysosporium and M. incrassata, 2ppm
tebuconazole in culture was used as the final concentration.
Cell extracts were prepared by harvesting mycelia and freeze drying. The frozen
mycelium was homogenized into a fine powder in a blender cup at 20 second intervals for 1 min.
The fine powder was resuspended in 50mM pottasim phospahate buffer containing 10%
glycerol. The homogenate was filtered and centrifuged at 105,00Xg for 90 min. at 4oC. The
microsomal pellet was resuspended in the same buffer. The supernatant and pellet were
analyzed for enzymatic activities. The centrifuge was a fixed angle rotor, induction drive,
Beckman model J2-21M.
4.2.3. Quantitative Determination of Total Proteins in Cultures
Potassium phosphate buffer was added to all cultures and solutions of the standard in B3 media.
The amount of protein in the crude cultures was quantified by measuring absorbance using
ultraviolet-visible (UV-Vis) spectrometry at 280 λ wavelength. Interference from other
compounds which absorb UV was minimized by measuring absorbances at 280 nm. The
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instrument was a Beckman DU®-65 spectrophotometer. The cuvettes holding the samples were
made of quartz, which does not absorb light at this wavelength. Standards of bovine serum
albumin (with known amounts of protein) were prepared and used to prepare the concentration
versus absorbance curve which was subsequently used to compare absorbance with that of the
unknown samples to estimate protein content. The standard curve was prepared using 0.0, 0.1,
0.2, 0.5, 1, 2.5, 5, and 10g/l concentrations.
4.2.4

Ion Exchange Chromatography

To separate proteins in the culture media, 200ml of fungal culture containing tebuconazole by
species were centrifuged and the supernatant concentrated before subjection to ion exchange
chromatography to separate the proteins based on their net charge. The instrument used was a
Biorad Biologic LD ion exchanger. DEAE cellulose was used as the stationery column. The
eluting solvents were buffer A: 20mM tris Hcl (low salt) and buffer B: 20mM tris Hcl buffer +
500mM Nacl (high salt). To make the stationary phase, 10g of DEAE cellulose was dissolved in
tris buffer, and the slurry was allowed to settle for 10 min. The supernatant containing fines was
decanted. This process was repeated twice to ensure the supernatant was clear. The column was
then packed with the DEAE cellulose at atmospheric pressure. The sample (100ml.) was loaded
on to the colomn. The flow through, wash, and fractions were all collected. A gradient was run
from 100% buffer A: 0% B up to 0% A and 100% B.
4.2.5

Testing Active Fractions

4.2.5.1 Protein Determination and Assay of Active Fractions
The flow through, wash, and fractions were dried to 10 ml each and the amount of protein in the
crude cultures was quantified by measuring absorbance using ultraviolet-visible (UV-Vis)
spectrometry at 280 λ wavelength. Each fraction (20ml.) was tested against 2ppm of the test
chemical (tebuconazole) to determine which one of them contained the active enzymes that
oxidize it. Because P450s utilize NADPH as the electron donor of the monooxygenation
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reactions, 10µl per ml of fraction of NADPH was added. The reaction mixture was incubated for
two days at room temperature. The reaction was stopped by addition of 6N Hcl.
4.2.5.2 Quantitative Determination of Tebuconazole Retained in Fractions
Five ml. of the mixture was extracted in SPE columns. The columns (Bond Elut –C18, 500mg,
3ml Varian #12102028) were preconditioned with two column volumes of methanol, followed
by two column volumes of milli-Q water. The sample was loaded and pulled through at one
drop per second, followed by a column rinse of 50:50 acetonitrile water. Retained compounds
were eluted with 4 column volumes of methanol collecting in 15ml centrifuge tubes. Each tube
was dried to below 5ml on a nitrogen evaporator and transferred to a second tube while passing
over sodium sulfate. The final volume was adjusted to 5ml. Samples were cleaned with a 0.2
µm Teflon™ filter prior to quantitative analysis by GC-MS. The GC-MS was an Agilent 6890
gas chromatograph using a 5973 mass selective detector. The injection port temperature was
250oC, detector temperature 280oC, and the carrier gas was helium at 1 mm min-1. The capillary
column model No. RTX35 was 30m X 250µmX 0.25µm. Injection volume was 2.0µl and total
runtime was 20.42 min. Tebuconazole eluted at 15.9 min. Running in selected ion mode (SIM),
ions detected for tebuconazole were 250 as the target ion, and 125 and 252 as the qualifier ions.
Calibration was done using a four point curve. Concentrations of the samples were calculated
using the formula: (X / V1)* (V2)*dilution factor.
Where:

X = off the curve reading from the instrument.
V1= initial vol. of sample extracted by SPE
V2= final vol. of sample after SPE

4.2.6

Induction and Inhibition Tests

Because Phanerochaete chrysosporium showed little ability to degrade tebuconazole, the rest of
the tests were carried out only for T. harzianum and M. incrassata. Separate flasks each with
100ml culture and tebuconazole were grown after supplementing the media with known P450
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inhibitors ABT and piperonyl butoxide. Similarly separate flasks were supplemented with
Phenobarbital, a known P450 inducer. The level of protein produced in the culture was
determined using the procedure in section 4.2.2.
4.2.7

Carbon Monoxide Difference Spectra

To further confirm the production of P450s, cultures containing tebuconazole alone,
tebuconazole with P450 inhibitors and those with phenobarbital the inducer were separately
centrifuged, concentrated, and subjected to determination of reduced CO difference spectra
according to the method of Omura and Sato (1964). In this method, an intense peak in the blue
wavelength region of the visible spectrum corresponding to a wavelength of maximum
absorption in the reduced form of heme-containing moieties, such as P450 is observed at 450nm
when saturated with carbon monoxide. Microsomal preparations and fractions found active in
section 4.2.3 were placed in sample cuvettes and a base line reading was obtained. Reduction of
samples was effected using 0.01g Na2S2O4. The content was then treated with carbon monoxide
(CO), and the spectral difference thereby induced mearsured. CO was carefully bubbled through
the sample for 20s to sufficiently saturate it before determination of spectra.
4.3

Results and Discussion

4.3.1

Protein in Culture Media

B3 media contained no proteins and was used to calibrate the spectrophotometer before
determination of protein content in each sample. Figure 4.1 shows the calibration curve obtained
using the standard. Figure 4.2 shows the total protein content in each culture. Tebuconazole did
not significantly affect the total amount of protein generated by each fungal species in the culture
media ( P=0.13, d.f 3). The total amount of protein therefore did not give an indication on the
effect of tebuconazole on amount of protein produced. The important factor lies in the type of
protein / enzyme produced.
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Figure 4.1. Standard curve for protein quantity.
4.3.2

Ion Exchange Chromatography

The chart recording of absorbance and time monitoring elution of proteins is shown in Figure
4.3. Absorbance gave an indication of eluting ions or proteins. From the chart recorders, all
target proteins for further analysis eluted from the column in the flow through and column wash
(i.e., before 250 min. and 10% buffer B) with the low salt buffer as the eluting buffer.
with tebuconazole
Control
1.40

Proteins (g/l)

1.20
1.00
0.80
0.60
0.40
0.20
0.00
P. chrysosporium

M. incrassata

T. harzianum

Figure 4.2. Protein quantity in cultures.
The compounds eluting in the collected fractions with high salt as buffer contained more of the
media components as shown in the blank. Fractions eluting after start of the gradient were
consolidated into three consecutive fractions based on the order of elution.
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4.3.3

Testing Active Ion Exchange Fractions

The wash, flow through, and fractions for each culture were concentrated by evaporation and
tested for ability to degrade tebuconazole. In the presence of the co-enzyme NADPH, the flow
through and wash in M. incrassata and T. harzianum were able to degrade tebuconazole. This
was not observed in the absence of NADPH. All fractions from P. chrysosporium showed no
activity. Amounts of tebuconazole remaining in the test solutions is shown in Figure 4.5. 38%
tebuconazole was degraded in the flow through of M. incrassata and 39% in the column wash.
In T. harzianum culture, 38% was degraded in the flow through and 50.1 % in the column wash.

Absorbance
units

Blank

Absorbance
units

P. chrysosporium

Absorbance
units

M. Incrassata

Absorbance
units

T. harzianum

Figure 4.3. Chart recording of absorbance and time
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Figure 4.4. Tebuconazole remaining in the test solutions of fractions
Proteins were produced in all cultures however, proteineous extracts produced in
P. chrysosporium cultures could not degrade tebuconazole while those in T. harzianum cultures
had the highest capacity to degrade tebuconazole.
4.3.4

Induction and Inhibition Tests

Inhibitor tests showed that cultures with P450 inhibitors ABT and piperonyl butoxide (PB) had a
reduced amount of protein produced and had less degradation of tebuconazole. The inhibitors
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ABT and PB both reduced the amount of tebuconazole depleted from cultures in cultures of both
T. harzianum and M. incrassata. PB inhibited degradation of tebuconazole to a lesser extent
than ABT. There was a significant difference in the amount of tebuconazole depleted in cultures
containing tebuconazole alone and those containing the inhibitors in addition to tebuconazole
(For ABT p=0.001 and p=0.03, df =5 in T. harzianum and M. Incrassata cultures respectively).
The culture with the inducer phenobarbital did not show a significant difference with that
containing only tebuconazole. Also, no effect on protein level in solution was observed with
phenobarbital. Phenobarbital did not induce or increase degradation of tebuconazole as
expected.
Table 4.1. Effect of P450 inhibitors and inducers on tebuconazole degradation and
protein production.
Species
M. incrassata

T. harzianum

4.3.5

Protein content
(g/l)

Tebuconazole retained in ppm
(% degraded)

Control

2.03

1.99 (0.5)

Tebuconazole only

1.89

1.75 (12.5)

ABT

1.69

1.93 (3.5)

Piperonyl butoxide

1.76

1.87 (6.5)

Phenobarbital

1.92

1.95 (2.5)

Control

1.8

20.12 (4.4)

Tebuconazole only

1.35

8.02 (59.9)

ABT

1.02

18.92 (5.4)

Piperonyl butoxide

1.54

16.82 (15.9

Phenobarbital

1.76

19.23 (3.85)

Carbon Monoxide Difference Spectra

A difference spectrum with a maximum peak at 440-460nm was observed when CO was bubbled
into the Na2S2O4 treated concentrated samples of T. harzianum culture extracts. The peak was
not apparent in M. incrassata samples most likely due to low concentrations of the enzymes.
The active fractions (the flow through and wash from the ion exchange column) also did not
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exhibit the spectra pattern typical to cytochrome P450 most likely due to low concentrations of
the enzymes.

0.3
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0.25
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T. harzianum

0.15
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0.1
Active fractions
of T. harzianum

0.05
0
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-0.1

Wavelength (nm)

Figure 4.5. CO difference spectra of culture extracts and fractions
The maximum absorbance at 450 mn is a confirmation that cytochrome P450 family of enzymes
are involved in the phase I metabolism of tebuconazole in T. harzianum. This spectral
confirmation was not observed for M. incrassata cultures.
4.4

Conclusions

It had previously been shown that T. harzianum and M. incrassata both metabolize tebuconazole
by initial oxidation reactions. This led to the hypothesis that monooxygenation is catalyzed by
enzymes from the family of the cytochrome P450s. The quantity of proteineous extracts
produced by cultures was not affected by the presence of tebuconazole. The oxidation of
tebuconazole by T. harzianum and M. incrassata was reduced when PB and ABT, both known
P450 inhibitors, were added to the culture than in cultures containing tebuconazole alone. This
suggested that the enzymes involved are from the P450 family. Furthermore, the microsomal
extract from T. harzianum exhibited a maximum peak at 440 - 460nm when CO was bubbled
into the Na2S2O4 treated concentrated samples. This indicates that initial oxidation reactions
leading to the metabolism of tebuconazole by the two species are cytochrome P450 dependent.
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CHAPTER 5. THE EFFECT OF ADDITIVES ON BIOTRANSFORMATION AND
EFFICACY OF TEBUCONAZOLE EFFICACY AGAINST MOLDS
5.1

Introduction

Several problems exist with totally organic wood preservative systems. Most are about 10-30
fold more expensive per pound than the inorganics (Schultz et al., 2004) and may not be used in
ground contact on their own. Currently, their major advantage is also their major disadvantage:
biotransformation by wood degrading and non degrading organisms in soil and wood. In
Chapter 2 and 3 it was shown that the mold Trichoderma harzianum, brown rot fungus
Meruliporia incrassata and the bacterial species Pseudomonas fluorescens all can metabolize
tebuconazole.
The primary metabolism of toxicants in plants often results in metabolites with reduced
or modified toxicity, increased polarity, and predisposition of the parent molecule to serve as
substrate for conjugation. The specific functional groups or linkages (e.g., hydroxyl, amino,
nitro, amide, halogen, carboxyl, and nitrile) found in the molecules of xenobiotics or endogenous
compounds are susceptible to chemical, physical, or enzymatic transformations. Enzymatic
transformation is by far the major means of detoxification and toxicants may be altered through
oxidative, reductive, or hydrolytic reactions or be activated to serve as reactive intermediates for
the subsequent conjugation of the parent molecules with endogenous substances such as sugars,
glutathione, or amino acids (Hatzios, 2005). Most of the reactions of the primary metabolism of
toxicants in plants are oxidative, catalysed by cytochrome P450 monooxygenases or esterases.
Some reductive reactions are known to occur, but they are not considered very important in the
primary metabolism of toxicants in plants.
Non-biocidal additives in combination with organic biocides may enhance efficacy and
lower the cost of organic wood preservative systems. Possible non-biocidal additives which
could be mixed with organic biocides include water repellents, antioxidants, and chelators for
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specific elements including metals required by wood decaying fungi such as iron and manganese.
It may be possible to tie up essential minerals, elements, or compounds such as amino acids
needed by fungi from obtaining essential elements such as N, P, and Ca (Green III and Schultz,
2003). The calcium chelating compound Na- N’ N-napthaloylhydroxamine (NHA, sodium salt)
has shown positive results as a co- biocide. Antioxidants may act synergistically to biocides by
disrupting the initial generation of free radicals which help open up cell walls. Finally, metals
such as Fe or Mn are well known to be involved in fungal degradation mechanisms, either as part
of an enzymatic system or as a free metal. Thus, addition of appropriate metal chelators might
prevent the metals from being available to the fungi (Schultz and Nicholas, 2001; Green III and
Schultz, 2003). Propyl gallate has dual antioxidant and Fe2+ metal chelating properties and gives
synergistic performance when combined with various biocides by interference with fungal redox
reactions (Binbuga and et al., 2005). The percent strength loss of 0.01% tebuconazole treated
southern yellow pine after exposure to G. trabeum in a soil block test was reduced from 82% to
6% after addition of 3% EDTA to the formulation. For T. versicolar, the improvement was from
23% to 3% (Schultz and Nicholas, 2001).
This work explores the efficacy of two P450 inhibitors piperonyl butoxide (PB) and 1Aminobenzotriazole (ABT) and two metal chelators N,N,N',N'-tetramethylethylenediamine
(TEMED) and ethylenediaminetetraacetic acid (EDTA) in preventing or reducing the effect of
monooxydenase activities which result in the initial oxidation of tebuconazole. PB is a synergist
used in a wide variety of insecticides: pyrethrins, pyrethroids, rotenone, and carbamates (Kakko
et al., 2000). In a study to assess its effect on the toxicity of chlorpyrifos an organophosphorus
insecticide against Ceriodaphnia dubia (waterflea) and Xenopus laevis (South African clawed
frog), PB at 200 µg/L reduced the toxicity of chlorpyrifos to C. dubia by a factor of 6. At 3000
µ/L it also reduced the toxicity of CPF to X. laevis with respect to mortality and malformations.
This led to the conclusion that C. dubia and X. laevis have the capability to metabolize
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chlorpyrifos via P450 mediated reactions (El-Merhibi et al., 2004). The study of the in-vitro Soxidation of fenbendazole and fenbendazole sulphoxide in rats showed that PB significantly
inhibited the sulphoxidation and sulphonation of fenbendazole. It was concluded that PB
inhibited the oxidative conversion of fenbendazole into inactive metabolites (Siminszky, 2006).
1-Aminobenzotriazole (ABT) is a mechanism-based inhibitor of animal cytochrome
P450. It results in a loss of 60-80% of P450 activity and drug oxidations in animal studies
In-vitro as well as in-vivo. An injection of 25 and 50 mg/kg body weight ABT to rats caused
concentration-dependent declines (60-80%) in adrenal mitochondrial and microsomal
cytochrome P450 concentrations (Omoto et al., 2003). ABT inactivates P450 via alkylation of
the prosthetic heme moiety causing loss of the characteristic P450 absorption spectrum.
EDTA is a substituted diamine chelate ligand with a high affinity constant to form metal
complexes. It is a powerful complexing agent of metals and is highly stable, offering a
considerable versatility in industrial and household uses. Applied predominantly in an aqueous
medium, it is released into the environment through wastewaters. It forms especially strong
complexes with Pb, Mn(II), Cu(II), Fe(III), and Co(III) (Abumaizar and Smith, 1999; Oviedo
and Rodríguez, 2003). It may inhibit mono oxygenation by chelating Fe3+ and Fe2+ ions
important in the P450 cycle. EDTA binds to metals via four carboxylate and two amine groups.
TEMED is a bidentate ligand widely employed as a ligand for metal ions. It forms stable
complexes with metal halides (e.g., zinc chloride, copper(I) iodide), giving complexes that are
soluble in organic solvents. Inhibiting the detoxification pathway allows higher unmetabolised
systemic concentrations of the active insecticide to remain within the timber for a longer period.
5.2

Materials and Methods

5.2.1

Test Chemicals

Ninety five percent tebuconazole (Preventol A 8) was provided by Lanxess Corp. (Pittsburgh,
PA) and the standard (99%) was obtained from Sigma Aldrich (St Louis, MO). Fungal species
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were provided by the US. Forest Products Laboratory (Madison, WI). Fungal cultures were
grown out and maintained on media containing 1.5% agar, 2% malt extract and 0.001% yeast
extract. ABT, PB, EDTA, and TEMED were obtained from Fisher Scientific (Waltham, MA).
5.2.2

Agar Block Tests

Growth media (600ml) containing 1.5% agar, 2% malt extract, and 0.001%yeast extract was
supplemented with tebuconazole (20ppm final concentration). This was divided into 5 groups
(groups 2-5) each with 90mls and further treated as shown below (Table 5.1) before pouring on
to agar block Petri dishes (approximately 25 ml. each). Group 1 was the control. Plates were
kept at 25oC. When the fungal mycelia reached the edges of the Petri dish in control cultures
(full diameter), the diameter of mycelia growth on all the Petri dishes was determined.
Table 5.1. Agar block test set up.
Treatment No.

Treatment

Group 1

Agar media only

Group 2

20ppm tebuconazole only, no further treatment

Group 3
Group 4

Supplemented with 10mls of 30% EDTA dissolved in distilled water
(at pH adjusted to 9 using KOH)
Supplemented with 10mls of 30% TEMED dissolved in acetonitrile

Group 5

Supplemented with 10mls of 3% PB

Group 6

Supplemented with 10mls of 3% ABT

5.2.3

Liquid Cultures and Preparation of Cell Extracts

Fifteen Erlenmeyer flasks each with 90mls B3 media were supplemented with 0.1ml of 0.2%
tebuconazole. Flasks were divided into five groups of three and further treated with additives as
shown in Table 5.2. Group 1 was the culture control with B3 media only. Flasks in groups 1-6
were inoculated with an agar plug from actively growing colonies. Group 7 was the substrate
control with tebuconazole but without innoculum. Cultures were incubated at 25oC and shaken
at 120rpm for 21days. All samples were centrifuged (10 min. at 15000xg and 4oC).
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Table 5.2. Liquid cultures set up
Treatment No.

Treatment.

Group 1

B3 media only

Group 2

20ppm tebuconazole only, no further treatment

Group 3
Group 4

Supplemented with 10mls of 30% EDTA dissolved in distilled water
(at pH adjusted to 9 using KOH)
Supplemented with 10mls of 30% TEMED dissolved in acetonitrile

Group 5

Supplemented with 10mls of 3% PB

Group 6

Supplemented with 10mls of 3% ABT

Group 7

20ppm tebuconazole only, no innoculum

The centrifuge was a fixed angle rotor, induction drive Beckman model J2-21M. The
supernatant was subjected to quantitative determination of retained tebuconazole and HPLC for
detection of metabolites.
5.2.4

Quantitative Determination of Tebuconazole Retained in Samples

Five ml of filtered medium was extracted in solid-phase extraction (SPE) columns. The columns
(Bond Elut –C18, 500mg, 3ml Varian #12102028) were preconditioned with two column
volumes of methanol, followed by two column volumes of milli-Q water. The sample was loaded
and pulled through at one drop per second, followed by a column rinse of 50:50 acetonitrile
water. Retained compounds were eluted with 4 column volumes of methanol and collected in
15ml. centrifuge tubes. Each tube was dried to below 5ml. on a nitrogen evaporator and
transferred to a second tube while passing over sodium sulfate. The final volume was adjusted to
5ml. Samples were cleaned with a 0.2 µm Teflon™ filter prior to quantitative analysis by gas
chromatography (GC-MS). The instrument was an Agilent 6890 gas chromatograph using a
5973 mass selective detector. The injection port temperature was 250oC, the detector
temperature 280oC, and the carrier gas was helium at 1 mm min-1. The oven was initially held at
80oC for 2 min. followed by a 30oC min.-1 increase to 190oC and then an 8oC min-1 increase to a
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final temperature of 300oC. The capillary column model No. RTX35 was 30m X 250µmX
0.25µm. Injection volume was 2.0µl, and total runtime 20.42 min. Tebuconazole eluted at 15.9
min. Running in selected ion mode (SIM), ions detected for tebuconazole were 250 as the target
ion, and 125 and 252 as the qualifier ions. Calibration was done using a four point curve.
Concentrations of the samples were calculated using the formula:
(X / V1)* (V2)*dilution factor.
Where:

[1]

X = value obtained from the curve.
V1= Initial vol. of sample extracted by SPE
V2= final vol. of sample after SPE

5.2.5

Preparation of Samples for HPLC Analysis

The remaining liquid samples were pooled into one composite sample per treatment.
Each sample was subjected to extraction and cleanup by the following procedure: sample was
transferred into a one liter separating funnel and 75ml. of dichloromethane added. The sample
was subjected to shaking for 1.5 min. vented every 20 seconds to release pressure, then left to
stand for 3 min. The bottom layer was passed over sodium sulfate into a 400ml beaker.
Extraction was repeated twice. The sample was then placed on a water bath at 45oC and
evaporated until almost dry. Five ml. of acetonitrile was added for solvent exchange, re-dried to
about 2ml, and transferred to a centrifuge tube with several rinses of acetonitrile while passing it
over sodium sulfate funnel. The tube was dried to below 5ml. on a nitrogen evaporator, and the
final volume adjusted to 5ml. before HPLC qualitative analysis.
5.2.6

HPLC Analysis

Several reverse-phase HPLC runs were necessary to detect and purify any metabolites. The
system consisted of a Waters 600 pump with a Waters 2487 UV detector whose output was
connected to a fraction collector. The column was a Waters Delta-Pak C18, 300 Å, 15 micron,
8mm x 10 cm radial compression module. Eluant composition as a function of time was:
66

isocratic from 0-5 min. 70% water+ 0.1% formic acid 30% acetonitrile, linear increases of
acetonitrile from 5-30 min. to 85% and isocratic at 85% acetonitrile for 5 min. Flow rate was
1 ml. min-1 and detection was at 224 nm wavelength. Tebuconazole eluted at 28 min.
Qualitative analysis using authentic standards of metabolites was not possible as metabolites of
tebuconazole could not be obtained. Tebuconazole peaks and those of metabolites were
identified by comparison of elution time, intact molecular mass, isotopic pattern distribution,
and identification of functional groups of (i) tebuconazole standard alone, (ii) the media only,
(iii) media containing tebuconazole before exposure to microorganisms, and (iv) media
containing tebuconazole after exposure to microorganisms.
5.2.7

Mass Spectral Characterizations

Exact mass determination of HPLC fractions of tebuconazole and its metabolites was performed
by electrospray ionization (ESI). The instrument operated in positive ESI mode was an Agilent
6210 Time of flight (TOF) LC/MS mass spectrometer.
5.2.8

The Mold Test

The effect of additives on the resistance of tebuconazole treated wood to the surface growth of
molds was determined in a mold test. Resistance was evaluated relative to ACQ treated and
untreated wood. The standard method for evaluating the resistance of wood product surfaces to
mold E 24-06 by the American Wood Preservers Association (AWPA, 2007) was used.
Samples were treated by vacuum and conditioned at room temperature. Treatment solutions
contained 0.1% tebuconazole and additive concentrations shown in Table 5.3. Retention of
tebuconazole in each sample was determined from initial weights and final weights after
treatment. A total of six treatments were exposed in an environmental chamber where
temperature and relative humidity were approximately 26o C and 98-100 %, respectively.
Sample locations in the camber were randomized. The chamber was inoculated using mold
suspensions with the following mold species: Aureobasidium pullulans, Aspergillus niger,
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Penicillium citrinum, and Alternaria tenuissima. The innoculum was evenly sprayed over the
soil surface in the chamber. After two weeks of sporulation and equilibration, test samples were
introduced and the innoculum evenly sprayed over the samples. The chamber was operated for
eight weeks. After 2, 4, 6, and 8 weeks exposure, the samples were visually rated for the extent
and intensity of mold growth.
Table 5.3. Set up of the mold test AWPA E 24-06.
Treatment No.

Treatment

1.

Untreated

2.

ACQ- 4.0 Kg/m3

3.

Tebuconazole

4.

Tebuconazole + 0.1% PB

5.

Tebuconazole+ 0.1% ABT

6.

Tebuconazole + 3% EDTA

5.3

Results and Discussion

5.3.1

Agar Block Tests

Growth of mycelia was observed on all Petri dishes. T. harzianum is resistant to tebuconazole
below 200ppm. At 20ppm, addition of the various additives did not prevent germination of
spores. The performance of the tebuconazole only treatment and that of tebuconazole mixed
with the metal chelators TEMED or EDTA had no significant difference on the extent of
germination and the diameter of mycelia observed. The increases in diameter for these
treatments were not significantly different (p=0.1, df =6). EDTA performed better than TEMED.
The P450 inhibitors PB and ABT had a synergistic effect with tebuconazole; both reduced the
growth in diameter significantly. ABT performed better than PB. However none of the
treatments was effective in preventing germination and growth of the fungus.
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Table 5.4. Diameter increase (mm) of T. harzianum mycelia after 7 days.
*(20ppm tebuconazole in all treatments).

Agar only (control)
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Percent decrease in diameter
to that of the control
control

Solvent only- acetonitrile)

76

0

Tebuconazole

74

2.6

Tebuconazole + EDTA

72

5.2

Tebuconazole + TEMED

75

1.3

Tebuconazole + PB

65

14.4

Tebuconazole + ABT

36

52.6

Treatment

5.3.2

Diameter of mycelia

Quantitative Determination of Tebuconazole Retained in Samples

The effect of the mono-oxygenase inhibitors PB and ABT and metal chelators EDTA and
TEMED on tebuconazole metabolism by T. harzianum was measured by the amount retained in
the culture media after 21 days incubation. Results are shown in Figure 5.1. Statistical analysis
of the five mean amounts of tebuconazole retained using ANOVA showed that the means were
significantly different (α=0.05, p=0.015 df =10). In cultures containing no additive, 49%
tebuconazole was depleted at the end of culture period. TEMED and EDTA had the least effect
and caused a decrease in tebuconazole depleted to 46.1% and 28.8%, respectively. PB and ABT
gave the best performance in terms of retaining tebuconazole in the culture by 19.7% and 14.6%,
respectively. This confirms the hypothesis that P450 type of enzymes is involved in the
metabolism of tebuconazole.
5.3.3

HPLC and Mass Spectrometry Analysis

Cultures with only tebuconazole had four metabolites in addition to the tebuconazole elute from
the column. The culture with TEMED had two metabolites while all other cultures had only one
metabolite elute in addition to tebuconazole. Further analysis of metabolites by mass
spectrometry for exact mass and Cl isotope pattern revealed that metabolites were mainly the
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Tebuconazole retained (ppm)

25

sample
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15

10
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0
Tebuconazole only

Tebuconazole+TEMED

Tebuconazole+EDTA

Tebuconazole+PB

Tebuconazole+ABT

Figure 5.1. Tebuconazole retained in samples.
oxidation product. There was no evidence of phase II metabolite products in all cultures except
those with tebuconazole only and those with TEMED in addition to tebuconazole. Figure 5.2
shows all the chromatograms. Fraction 2 in TEMED containing cultures was the same as
fraction 4 of the tebuconazole only fraction. This indicated there was further metabolism after
the initial oxidation. In all other treatments, only the initial oxidation product with molecular
weight of 324.14 was identified. Table 5.5 shows the molecular ions detected in the mass
spectra. Despite oxidation products being present in all treatments, the cultures with P450
Inhibitors PB and ABT had the least amount of metabolites and only the initial oxidation product
with molecular weight of 324.15 was observed. This fraction had the Cl isotope pattern,
confirming that apart from addition of the oxygen, no further change occurred in the structure of
tebuconazole.
5.3.4

Mold Test

Relative resistance to mold growth was determined by comparing average ratings of six
replicates of each treatment (Table 5.6). In the mold test all treatments with additives in the
formulation showed a better performance than the treatment with tebuconazole only. The
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Figure 5.2. HPLC chromatograms of the treatments.
treatment with tebuconazole only and tebuconazole with TEMED did not perform as well as
ACQ. All other treatments at an average retention of 0.16 kg/m3 gave a performance similar to
that of ACQ at 4.0 kg/m3. The species used in the mold test; Aureobasidium spp., Aspergillus
spp., Penicillium sp.p and Alternaria spp. all have much lower MICs (< 200ppm) than
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Trichoderma sp (> 1000ppm) (Grundlingerv and Exner, 1990). This explains why all
formulations showed a better performance in the mold test as compared to the agar block test
using T. harzianum.
Table 5.5. Mass spectra - major peaks for each treatment.
Sample

Peaks detected
(m/z, amu)
308.15, 309.16, 310.14

Most intense peak
(% Intensity)
308.15

Fraction 1

308.15, 324.16, 338.34

338.34

Fraction 2

324.14

Tebuconazole standard
Culture with
tebuconazole only

Tebuconazole + EDTA

Fraction 1

306. 13, 308.15, 312.15,
338.34, 371.11, 324.15
308.15, 310.15, 338.34,
364.17 366.12
281.17, 308.15, 310.15,
338.34, 312.15
308.15, 281.14, 310.14,
324.15
308.15, 281.14, 282.15,
283.14,
308.15, 310.14, 324.15

Tebuconazole + PB

Fraction 1

308.15, 310.15, 324.15

308.15, 324.15

Tebuconazole +ABT

No major
fraction
identified

308.15, 310.15, 324.15

308.15, 324.15

Fraction 3
Fraction 4
Tebuconazole + TEMED

Fraction 1
Fraction 2

366.12
281.17
324.15
281.14
308.15, 324.15

PB and ABT most likely work synergistically with tebuconazole in inhibiting the the fungal
cytochrome P-450 3-A dependent enzyme 14-alpha demethylase, thereby interrupting the
synthesis of ergosterol. EDTA had an effect on the magnitude of oxidation. As hypothesized,
EDTA most likely binds metal ions like Fe 2+ and Fe3+ which are important in the P450
enzymatic system, thus, interfering with tebuconazole metabolism. However, despite the
positive effect of all these inhibitors an important observation was that T. harzianum was able to
germinate and grow to some extent in the presence of tebuconazole and all additives used in this
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study. This led to the conclusion that P450 inhibitors, like triazoles, cannot be effective against
Table 5.6. Retentions of tebuconazole and mold growth on wood samples.
Treatment

Tebuconazole
retention
Kg/m3
-

Untreated
3

Average rating
2 weeks

4 weeks

6 weeks

8 weeks

0

4

4

4

ACQ- 4.0 Kg/m

-

0

0

0

0

Tebuconazole

0.16

0

0

2

2

Tebuconazole + PB

0.18

0

0

0

0

Tebuconazole+ ABT

0.152

0

0

0

0

Tebuconazole + EDTA

0.153

0

0

0

0

Tebuconazole+ TEMED

0.142

0

0

0

2

0-No visible growth.
1- Mold covering 10% of surface.
2- Mold covering 10-30% of the surface.
3- Mold covering 30-70% of the surface.
4- Mold covering more than 70% of the surface.
5- Mold covering more than 100% of the surface with intense growth obscuring greater than 70% of the surface.

resistant molds. Biotransformation of the active chemical may also not be the only mechanism
used by these fungi in tolerating tebuconazole. Genetic over expression of the CYP 51- gene
which leads to overproduction of the P-450 dependent enzyme 14-α demethylase may contribute
to the resistance leading to germination and growth of the fungus in unfavorable environments.
The preservative of choice for these organisms most likely is one whose mode of action is
different from interruption of ergosterol synthesis. The spores produced may have enough sterol
to germinate in the presence of these inhibitors.
5.4

Conclusion

Cytochrome P450 monooxygenases are involved in cases of resistance of fungi to fungicides.
Resistance has been associated with an increase in monooxygenase activities due to cytochrome
P450 activities. However, this increase does not account for all of the resistance in T.
harzianum. Even though metabolism of tebuconazole was drastically reduced by the P450

73

inhibitors ABT and PB, T. harzianum was still able to germinate and grow at concentrations less
than 200ppm tebuconazole in the presence of these additives. This led to the conclusion that
biotransformation of the chemical is not the only mechanism by which this species tolerates
tebuconazole. Tebuconazole does not adequately hinder P450 activities. ABT and PB increase
the hindrance of P450 activities. The metal chelators also may slow down the P450 activities but
do not eliminate them completely. In addition to biotransformation, there are other mechanisms
by which this species tolerates tebuconazole. Tebuconazole, PB, and ABT all seem to have little
effect against spore germination because spores may contain enough ergosterol for formation of
germ tubes. Some spores may have enough sterol to produce infection structures hence
tebuconazole may not be effective against infection of wood in service. Another reason may be
genetic over expression of the CYP 51- gene which leads to overproduction of the P-450
dependent enzyme 14-α demethylase. Therefore, synthesis of ergosterol is not interfered with as
expected and this leads to germination and growth of the fungus in unfavorable environments.
5.5
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CHAPTER 6. CONCLUSIONS
The objective of this work was to study the extent of biodegradation and metabolic pathways by
microorganisms and the contribution it has on the tolerance of some fungal species to biocides.
Currently, the major advantage of organic biocides used in wood preservation is also their major
disadvantage: they are biodegradable or transformed by wood degrading and non degrading
organisms in soil and wood. Tebuconazole, a triazole, was used as the test compound. One
species each of a bacterial strain, a mold, a brown rot species and a white rot species were used
as the test microorganisms.
The mold T. harzianum was found able to tolerate tebuconazole at concentrations below
200ppm because it biotransforms the chemical by cleavage of the 1,2,4 triazole ring and by
performing oxidation reactions to produce more hydrophilic metabolites. The tert butyl alcohol,
the tert butyl carboxylic acid, and the 3-hydroxyaryl derivatives are the initial products. These
initial products undergo acetylation or methylation in a second step. Further studies using
different species of fungi revealed that the ability of a fungus to degrade a biocide contributes to
the efficacy of the biocide against that species. P. chrysosporium with the lowest minimum
inhibitory concentration (MIC) was found not able to degrade tebuconazole o a significant
amount, while T. harzianum with the highest MIC (lowest efficacy) degrades tebuconazole and
tolerates it at concentrations less than 200ppm. Although P. chrysosporium is recognized for its
ability to metabolize a large diversity of compounds, it showed little or no ability to metabolize
tebuconazole. This may be a contributing factor to the high efficacy of tebuconazole towards
white rot fungi. A common mechanism was involved in the initial metabolism of tebuconazole
by the different types of microorganisms studied. The most prominent metabolism product in
cultures of brown rot M. incrassata, the mold T. harzianum, and bacteria Pseudomonas
fluorescens had the 1,2,4 triazole ring cleaved to form imines. Two products with the same
molecular mass were identified. All species also perform oxidation processes in initial
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degradation of tebuconazole. The main products are the oxidation products of the methyl groups
on the tert butyl moiety (the alcohol and the carboxylic acid). T. harzianum is able to perform
phase II type reactions by acetylation and O-methylation. Brown rot M. incrassata and the
bacteria did not metabolize the chemical by acetylation.
Observation of mainly oxidation products led to the hypothesis that monooxygenation is
catalyzed by enzymes from the family of the Cytochrome P450 monooxygenases. The oxidation
of tebuconazole by T. harzianum and M. incrassata was reduced when PB and ABT, both known
P450 inhibitors, were added to the culture than in cultures containing tebuconazole alone. This
suggested that the enzymes involved are from the P450 family. Furthermore, the microsomal
extract from T. harzianum exhibited a maximum peak at 440 - 460nm when CO was bubbled
into Na2S2O4 treated and concentrated samples. This indicates that initial oxidation reactions
leading to the metabolism of tebuconazole by wood inhabiting fungi are cytochrome P450
dependent. Resistance is associated with an increase in monooxygenase activities and with an
increase in cytochrome P450 content. However, this increase does not account for all of the
resistance in T. harzianum. Even though metabolism of tebuconazole was drastically reduced by
the P450 inhibitors ABT and PB, T. harzianum was still able to germinate and grow at
concentrations less than 200ppm tebuconazole in the presence of these additives. This indicates
that biotransformation of the chemical is not the only mechanism by which this species tolerates
tebuconazole. Tebuconazole does not adequately hinder P450 activities. ABT and PB increase
the hindrance of P450 activities. The metal chelators also may slow down the P450 activities but
do not eliminate them completely. In addition to biotransformation, there are other mechanisms
by which this species tolerates tebuconazole. Tebuconazole, PB, and ABT all seem to have little
effect against spore germination because spores contain enough ergosterol for formation of germ
tubes. Some spores may have enough sterol to produce infection structures hence tebuconazole
may not be effective against infection of wood in service. Another reason may be genetic over
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expression of the CYP 51- gene which leads to overproduction of the P-450 dependent enzyme
14-α demethylase. Therefore, synthesis of ergosterol is not interfered with as is expected and
this leads to germination and growth of the fungus in unfavorable environments. The triazole
group of fungicides does not adequately protect timber against molds hence suitable co-biocides
may be necessary in any formulation containing triazoles. Molds like T. harzianum and bacteria
species are not responsible for decay but may lower biocide concentrations or metabolize them
into less potent derivatives making the environment suitable to wood degrading microorganisms.
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